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ABSTRACT
DE-CODING THE IMPACT OF EVOLVED CHANGES IN GENE
EXPRESSION AND CELLULAR PHENOTYPE ON PRIMATE EVOLUTION
FEBRUARY 2020
TRISHA M. ZINTEL
B.A., ARCADIA UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST

Directed by: Professor Courtney C. Babbitt, PhD

The goal of the dissertation work outlined here was to investigate the influence
of proximal processes contributing to evolutionary differences in phenotypes among
primate species. There are numerous previous comparative analyses of gene expression
between primate brain regions. However, primate brain tissue samples are relatively
rare, and my results have contributed to the pre-existing data on more well-studied
primates (i.e. humans, chimpanzees, macaques, marmosets) as well as produced
information on more rarely-studied primates (i.e. patas monkey, siamang, spider
monkey). Additionally, the primary visual cortex has not previously been as extensively
studied at the level of gene expression as other brain regions in primates. My
investigations of differences in cell biology between human and chimpanzee fibroblasts
and iPSC-derived neural cells will contribute to the fields’ understanding of the
influence of gene expression on differences in cell biology. While iPSC technology has
been used extensively to investigate neurological disease in vitro, it has not been used to
investigate differences in neural function between species. These data will be relevant
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both for determining proximate influences on evolutionary differences in neural
function across primates and the limitations of use of non-human primate models of
neurological disease.
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INTRODUCTION

The importance of investigating primate variation to better understand uniquelyhuman phenotypes
Though primates exhibit widespread variation in many phenotypes, including anatomy,
behavior, and cognition, the extent of these phenotypic differences is not substantially larger
than differences in genome sequence (Varki and Altheide, 2005; Varki and Varki, 2015). In
1975, decades prior to sequencing the entire human genome, King and Wilson hypothesized
that phenotypic differences amongst humans and chimpanzees must largely be due to changes
in gene expression, as coding sequence differences were not nearly divergent enough to account
for those differences (King and Wilson, 1975). Subsequent investigations into differential gene
expression across species, and primates in particular, have reinforced the hypothesis that noncoding, cis-regulatory changes are critical for these large differences in phenotype (Haygood et
al., 2007; Babbitt et al., 2010; Bauernfeind et al., 2015). Recent work has determined that
changes in gene expression in the brain have been found to be both functionally and
evolutionarily important (Khaitovich et al., 2004; Oldham et al., 2006; Babbitt et al., 2010,
2011; Kuzawa et al., 2014; Bauernfeind et al., 2015). Changes in non-coding regions of the
genome identified to be under positive selection in humans are enriched for biological processes
and molecular functions that are neural-specific (e.g. synaptic signaling) and those related to
cellular metabolism (e.g. carbohydrate and lipid metabolism) in various studies of human,
chimpanzee, and rhesus macaque brains (Babbitt et al., 2010; Haygood et al., 2010;
Bauernfeind et al., 2015).
Within primates, selective differences in the genome can be linked to diet and
metabolism, suggesting selection has optimized different metabolic processes in lineagedependent ways (Stringer & Andrews, 1988; Schaffner et al., 2005; Fagundes et al., 2007;
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Babbitt et al., 2010, 2011; Haygood et al., 2010; Bauernfeind et al., 2015). The human brain is
more energetically costly than that of other primates, utilizing ~ 20% of all of the body’s
metabolic resources, in comparison to non-human primate brains that use less than 10% (Mink
et al., 1981; Hofman, 1983). Importantly, allometry alone does not explain the increase in
human brain appropriation of glucose metabolism at this proportion (Karbowski, 2007; Martin,
1981; Yu et al., 2014). There is evidence that sheer increase in neuron number can explain at
least part of the energetic demand of the human brain (Herculano-Houzel, 2011). However,
interspecies differences in the contribution of metabolism of various neural cell types to
metabolic capacity at the organ level remain largely un-explored.
Many of these changes in brain metabolism have been hypothesized to coincide with
other trait changes, particularly those related to shifts in diet known to be important in hominin
evolution, such as an increase in meat products, increased quality of food, and agriculture
(Aiello and Wheeler, 1995; reviewed in Babbitt et al., 2011; Brown et al., 1985; McHenry,
1994, 1992; Peters, 2007; Shea, 2007). A recent study investigating an extensive number of
primates is consistent with this notion, determining that the best predictor of brain size was diet,
rather that social group structure (DeCasien et al., 2017). The expensive-tissue hypothesis posits
that a trade-off in energy allocation for the development of a larger, metabolically demanding
brain in primates coincided with a reduction in gut tissue (Stearns, 1992; Aiello & Wheeler,
1995; West et al., 2001; Pontzer et al., 2014). Similarly, an increase in energy-storing tissue
(adipose tissue) at the expense of energetically demanding muscle tissue may have also allowed
for greater allocation to a larger brain (Leonard et al., 2003; Leonard and Marcia, 1994; Leonard
and Robertson, 1997). Investigations of energy budget are a part of a larger effort to elucidate
trade-offs between metabolically relevant tissue types throughout primate evolution that might
explain unique primate traits, such as longer lifespans, protracted development, and increased
relative size of metabolically expensive tissues (i.e. brain) (Charnov and Berrigan, 1993;
Lovegrove, 2009; Pontzer et al., 2014; Snodgrass et al., 1999; Speakman, 2005). Indeed, there is
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evidence that the higher metabolic costs of the human brain influences the protracted
development of body growth rate (Kuzawa et al., 2014). Evolutionary differences in brain
metabolism are a subset of studied differences in metabolic traits that exhibit intriguing
differences across primate species. Primates exhibit a lower total energy expenditure (TEE) to
body size ratio than non-primates, and furthermore, humans have greater TEE than closely
related great ape species (chimpanzees, bonobos, gorillas, and orangutans) due in large part to
increased basal metabolic rate (BMR), all of which is consistent with the reallocation of
metabolic investment to brain (Pontzer et al., 2016, 2014). These in vivo (whole organism)
studies further suggest an important link between evolutionary differences in metabolism and
the uniqueness of the primate brain.
Similarly to organism-level investigations, there is also molecular evidence supporting
the evolution of metabolic processes (e.g. oxidative phosphorylation) in the primate brain with
phylogenetic proximity to humans. Within anthropoids, genes encoding the subunits of
cytochrome c oxidase, the final component of the electron transport chain, show an accelerated
rate of evolution in their sequences compared with any other placental mammals [1]. These
changes at the gene level are indicative of increased control over the mechanisms that process
glucose [2-6]. Further understanding gene-phenotype relationships between genetic changes
(both in coding and non-coding regulatory portions of the genome) and observed metabolic
differences in primates will contribute to a greater understanding of proximate influences on
larger evolutionary trends in primates.

Evolved changes in gene expression have significantly impacted primate evolution
in a variety of traits
Cellular metabolism involves the breakdown of fuel molecules to produce energy or
other molecules through multiple interconnected pathways, including glycolysis, oxidative
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phosphorylation, and the pentose phosphate pathway. Enrichments for metabolic processes in
genes and gene regulatory regions undergoing positive selection is a common thread in gene
expression analyses from whole primate brain tissue (Babbitt et al., 2010; Bauernfeind et al.,
2015; Haygood et al., 2010, 2007; Kosiol et al., 2008; Uddin et al., 2008). However, there are
lineage-dependent differences in the specific pathways enriched between species (e.g. glucose
and carbohydrate metabolism in humans and glycogen and acyl-CoA metabolism in
chimpanzees) (Haygood et al., 2007; Kosiol et al., 2008; Uddin et al., 2008) as well regions of
accelerated genomic change in a lineage-dependent manner (Pollard et al., 2006; Prabhakar et
al., 2006). These findings highlight a need to investigate not only glucose metabolism and
energy production but also that of other macromolecules (e.g. lipids, amino acids, nucleic acids)
for a more comprehensive understanding of differences in cellular metabolism in neural cells of
primates. Furthermore, unpublished data from our lab from a different study to the one planned
here has determined that genes significantly differentially expressed in multiple brain regions
between humans and chimpanzees are enriched for metabolic functions related to lipid and
carbohydrate metabolism, suggesting this is important for many cortical areas (further discussed
in Goal 2: Pilot Results). While previous work at the organ level highlight a difference in brain
metabolism, a cell-type specific comparison is necessary to understand distinct cellular
contributions to interspecific differences in neurological function (Gallego Romero et al., 2015).
Recent advancements in generating induced pluripotent stem cells (iPSCs) and further
development and refinement of protocols for differentiation of iPSCs has revolutionized our
ability to investigate uncommon cell types without invasive collection techniques. These
advancements make investigating evolved differences in cell biology in primates, for which
samples are rare, far more feasible. Comparisons of gene expression between iPSCs of different
species have found them to be a useful tool for studying inter-species differences, including
those between closely related primates (Gallego Romero et al., 2015; Wunderlich et al., 2014).
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Harnessing contemporary cell and molecular techniques to investigate classic
questions in biological anthropology
Evolved differences in metabolic investment may be the basis for a number of primatespecific phenotypes, including those that are uniquely-human, such as slow reproduction and
growth and correspondingly longer lifespan than other placental mammals (Charnov and
Berrigan, 1993; Pontzer et al., 2014; Snodgrass et al., 1999). Adaptation can act on metabolic
phenotypes through alterations to energy budget including reductions of or increases in total
energy budget or differential allocation of energy within energy budget (Lovegrove, 2009;
Pontzer et al., 2014; Speakman, 2005). In addition to energy allocation, adaptive changes in diet
(e.g. ability to differentiate nutrient poor vs nutrient rich food, tool use) also likely contributed
to the enlargement of the brain, particularly in the human lineage (reviewed in Babbitt et al.,
2011). The proposed work aims to bridge hypotheses about the influence of gene expression on
phenotypic differences amongst primates with trade-off hypotheses about the evolution of a
larger brain at the expense of other metabolically demanding tissue types ( King & Wilson,
1975; Leonard & Marcia, 1994; Aiello & Wheeler, 1995; Leonard & Robertson, 1997; Leonard
et al., 2003) by investigating altered gene expression in an under-studied, but critical brain cell
type with known metabolic relevance. My results would provide valuable insights into
astrocyte-mediated differences in metabolic brain function as a proximate mechanism by which
the ultimate evolutionary trajectory of human brain evolution may have occurred. The novel
technical approach I outline here would provide the larger biological anthropology community
with candidates of specific metabolic processes for which primates are experiencing adaptation,
and have the potential to inform studies of metabolic phenotypes in primates that are not
astrocyte- or brain-specific (i.e. evolved differences in primate energy budget). Determining
processes in which there are lineage-specific differences in gene expression and cellular
function, as I aim to do in with this project, can indirectly inform studies of organism-level
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energetics by elucidating what processes, and the functional consequences of, are experiencing
adaptation on the human lineage.

Summary of presented work
In conducting my dissertation research, I investigated how differences in gene
expression influence phenotypically diverse traits between primate species. To do this, I
coupled next-generation sequencing (RNA-Seq) and cell biology techniques (cell
culture, induced pluripotent stem cells (iPSCs), immunohistochemistry) to investigate
the influence of differential gene expression on observable differences in tissue- and
cellular-level traits between primate species. This included three major projects: 1)
investigating the evolution of gene expression in the primary visual cortex of primate
brains, 2) determining cellular differences in adhesion and migration between humans
and chimpanzee fibroblasts, and 3) investigating evolutionary differences between
neural cells in different primate species using iPSC-derived neurons and astrocytes.
Each of these projects are in different stages of completion. Here, I briefly introduce
each but full descriptions of these projects follow this introduction.
Chapter 1: Ecological trait differences are associated with gene expression in
the primary visual cortex of primates. There is evidence that divergence in substructures
of the brain may be equally as important phenotypically and evolutionarily as relative
brain size (Aristide et al., 2016). Furthermore, multiple studies on brain gene expression
have identified differences in gene expression based upon brain region (Khaitovich et
al., 2004; Oldham et al., 2006; Bakken et al., 2015; Bauernfeind et al., 2015). The goal
of this project was to determine differential expression across a wide range of primates
in an understudied brain region, the primary visual cortex (V1). This project is a subset
6

of a larger project comparing global gene expression (via RNA-Seq) across four brain
regions (cerebellum, hippocampus, prefrontal cortex, and visual cortex) between 18
primate species, of which I am a co-author on and played a main role in sample
preparation, sequencing, and computational pipeline development. The data presented
here for this project focuses on differential gene expression in the V1 using genomeguided determination of gene expression in 13/18 primate species for which genomes
are available. Significantly differentially expressed genes were determined between
species (i.e. human – chimpanzee), between groups of species belonging to different
taxa (i.e. all apes vs all old-world monkeys), and between groups of species that differ
in phenotypic traits (i.e. all arboreal species vs all terrestrial species). Differential
expression (DE) of genes in the visual cortex between species were enriched for many
different pathways, including those related to disease, adhesion, signaling, metabolism
and neural-specific processes. Genes DE between humans and chimpanzees were
enriched for more unique pathways than any other interspecies comparison. Differential
expression detected based entirely on comparing arboreal to terrestrial species was
enriched for synaptic neural processes more than any other DE comparison based on
other phenotypes (i.e. color vision) or differences in phylogeny. I found that while
metabolic signaling differs consistently across the primate tree, neural-specific signaling
(e.g. synaptic signaling) is far more conserved, except with evolutionary proximity to
humans: humans and chimpanzees were the only two species that exhibited significant
differences in synaptic signaling. This project is completed and a manuscript of these
results is in progress to be submitted for publication in November 2019 to BMC
Evolutionary Biology.
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Chapter 2: Chimpanzee fibroblasts exhibit greater adherence and migratory
phenotypes than human fibroblasts. Primates differ in a number of different phenotypic
traits, including that of disease (Varki & Altheide, 2005; Varki & Varki, 2015). More
specifically, it has been noted that cancer rates differ significantly between humans and
chimpanzees. Epithelial neoplasms, such as breast or lung carcinomas, are responsible
for at least 20% of human deaths but account for less that 2% of chimpanzee deaths
(Puente et al., 2006). Previous work from our lab determined that human and
chimpanzee fibroblasts are significantly different in (A) adhesion-related gene
expression when mimicking a wound healing / cancer response in vitro and (B)
proportions of focal adhesions in vitro (Advani et al., 2016).The goal of this project was
to determine if these previous findings related to adhesion translates into fundamental
differences in the cellular phenotypes of adhesion and migration between human and
chimpanzee fibroblasts in vitro. In collaboration with Shelly Peyton’s lab at UMass
Amherst, preliminary experiments comparing human and chimpanzee fibroblast
adhesion and migration in the presence of external fluid force determined that
chimpanzee fibroblasts adhered at greater proportion within one hour than human
fibroblasts did without observable differences in migration speed or distance over the
entire 12-hour time course. A wound healing assay determined that chimpanzee
fibroblasts exhibit greater adhesion and migration than human fibroblasts. Finally, the
same serum-challenge that mimics cancer progression / wound healing that produced
the aforementioned previous results of differences in adhesion gene expression will be
replicated in these experiments to determine interspecies differences in adhesion and
migration in this context. This project is completed and a manuscript of these results is
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in progress to be submitted for publication in November 2019 to Evolutionary Medicine
and Public Heath.
Chapter 3: Investigating cell-type specific shifts in metabolic gene expression
between human and chimpanzees. Project one focused on whole-brain tissue differential
expression across primate species and determined enrichment for metabolic and neuralspecific processes in differential expression between humans and chimpanzees.
However, the brain consists of several different cell types for which there are cell-type
specific metabolic and neural functions. For example, astrocytes promote neural
function by buffering extracellular conditions and by shuttling important metabolites to
neurons and even play an important role in neuron-neuron communication (i.e. synaptic
transmission) (Almad et al., 2016; Chandrasekaran et al., 2016; Zhao et al., 2017). To
investigate differences in species-specific gene expression and function in a cell-type
specific manner, I compared human and chimpanzee iPSC-derived neurons and
astrocytes. This involved differentiation of iPSC lines into multipotent neural progenitor
cells (NPCs) and subsequent differentiation of separate populations of NPCs into
neurons and astrocytes. Homogenous populations of neurons and astrocytes, per each
species, will be validated via immunohistochemistry for cell-identity and will be used
for RNA-Seq to determine differential gene expression in a cell-type by species manner.
Our results comparing expression between species demonstrates that astrocytes play a
significant role in altered metabolic gene expression.
With these outlined projects, I have further elucidated the influence of proximal
processes contributing to evolutionary differences in phenotypes among primate
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species. There are numerous previous comparative analyses of gene expression between
primate brain regions. However, primate brain tissue samples are relatively rare, and my
results have contributed to the pre-existing data on more well-studied primates (i.e.
humans, chimpanzees, macaques, marmosets) as well as also produced information on
more rarely-studied primates (i.e. patas monkey, gibbon, spider monkey). The primary
visual cortex has also not been as extensively studied as other brain regions in primates.
My investigations of differences in cell biology between human and chimpanzee
fibroblasts and iPSC-derived neural cells will contribute to our understanding of the
influence of gene expression on differences in cell biology. While iPSC technology has
been used extensively to investigate neurological-disease in vitro, it has not been used
to investigate differences in neural function between species. These data will be
relevant both for determining proximate influences on evolutionary differences in
neural function across primates and limitations of use of non-human primate models of
neurological disease.
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CHAPTER 1

ECOLOGICAL TRAIT DIFFERENCES ARE ASSOCIATED WITH GENE
EXPRESSION IN THE PRIMARY VISUAL CORTEX OF PRIMATES

1.1 Abstract1
Background: Primate species differ drastically from most other mammals in how they visually
perceive their environments, which is important for foraging, predator avoidance, and detection
of social cues. Although it is well established that primates display diversity in color vision and
various ecological specializations, it is not understood how visual system characteristics and
ecological adaptations may be associated with gene expression levels within the primary visual
cortex (V1).
Results: We performed RNA-Seq on V1 tissue samples from 28 individuals, representing 13
species of anthropoid primates, including hominoids, cercopithecoids, and platyrrhines. We
explored trait-dependent differential expression (DE) by contrasting species with differing
visual system phenotypes and ecological traits. Between 4-25% of genes were determined to be
differentially expressed in primates that varied in type of color vision (trichromatic or
polymorphic di/trichromatic), habitat use (arboreal or terrestrial), group size (large or small),
and primary diet (frugivorous, folivorous, or omnivorous). Our DE analyses revealed that
humans and chimpanzees showed the most marked differences between any two species,
despite the fact that they are only separated by 6-8 million years of independent evolution.
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Pathway enrichment analyses of DE genes demonstrated that changes in cellular metabolic
pathways (e.g. glycolysis) contribute to altered gene expression in primate V1 more than
neuron-specific processes (e.g. synaptic signaling). The exception to this trend is between
human and chimpanzee, which exhibited DE for a number of processes related to cholinergic
and GABAergic synaptic signaling.
Conclusion: Our data significantly expand the number of primate species for which V1
expression data exists. These results show a combination of species-specific and trait-dependent
differences in the evolution of gene expression in primate V1. We also show that humanspecific changes in brain gene expression extend to the primary visual cortex in a manner
similar to that reported of other brain regions.
1.2 Background
In most mammals, vision is critically important for the purposes of foraging, predator
avoidance, and mate recognition [7-11]. However, primates are distinguished from other
mammals by unique visual traits, including high visual acuity and variation in color perception
[8, 11-15]. Primates with forward-facing eyes have high orbital convergence and
correspondingly enhanced binocular vision resulting in greater depth perception (stereoscopic
vision) and increased visual acuity [16]. Primates also possess a uniquely specialized fovea, a
localization of cone receptors in the retina, that allows for greater resolution [17, 18]. Among
primates, visual acuity is highest in diurnal haplorrhine species [19-23]. Trichromatic color
vision is a hallmark of hominoid and cercopithecoid species, but color vision varies
significantly across platyrrhine species as well as within some species that have polymorphic
sex-linked di/trichromacy [24].
Higher visual acuity and a shift to trichromatic color vision are hypothesized to confer a
number of benefits across primate species. High visual acuity has been suggested to be
adaptively favorable in relation to diet (i.e. detecting insects) as well as for arboreal species
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navigating tree limbs [16]. At the level of opsin gene conservation across primates and tree
shrews, typical light conditions that require enhanced visual acuity are the same as those in
which color vision is favored, representing a putative adaptive link between enhanced acuity
and trichromacy [14]. The evolution of a third opsin gene increases the range of detectable
wavelengths (especially in the range of red hues) and has been hypothesized to be influenced by
foraging and social pressures [25, 26]. The foraging hypothesis stresses the importance of
detecting red ripe fruits and young leaves against a green foliage background [7-9, 27, 28]. The
social signal hypothesis states that wavelength sensitivity for red hues is important for accurate
interpretation of skin color changes indicative of receptivity, sociality, or health [25, 29, 30].
Evidence in a lemur species with mixed populations of trichromats and dichromats showed that
there is a group level benefit when at least a single trichromatic individual is present, likely
linked to the ability to locate ripe fruit during the dry season, thus positively influencing fitness
[28].
The primary visual cortex (V1) is the first cortical region in the visual pathway and
where visual inputs converge from both eyes. Inputs from both eyes that impart binocular
vision are critical for detecting edge orientation, thus playing an important role in depth
perception [15, 31]. Increased orbital convergence allowing for binocular vision correlates with
an increase in size in brain regions associated with visual perception [32]. Neuronal density
within V1 of primates is more than twice that of other mammals, reflecting the importance of
vision for primates [15, 16]. There is also known variation in V1 neuronal cytoarchitecture
across hominoid species, including molecular differences in cytochrome oxidase staining in
layer 4A [33, 34] and interneuron density [35, 36] as measured by immunohistochemistry.
Taken together, these findings may indicate an adaptive advantage of visual processes that
could differentially influence V1 function in primates. However, we still have little knowledge
about the genetic mechanisms driving V1 variation across species and how this correlates with
differences in visual acuity and perception.
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King and Wilson [37] hypothesized that the extensive phenotypic differences between
humans and chimpanzees must be due to changes in gene expression rather than codingsequence evolution, given the high degree of similarity at the nucleotide and protein levels.
Investigations of differential expression (DE) across primates have demonstrated that cisregulatory changes are critical for large-scale differences in phenotype [38-42]. Gene expression
tends to vary in different tissues of the body, and different regions of the brain are known to
have region-specific profiles indicative of localized regulation [43-48]. Enrichments for neuronspecific processes (e.g. synaptic signaling) and metabolism (e.g. carbohydrate and lipid
metabolism) have been reported in human brain gene expression in comparison to that of
chimpanzee and rhesus macaque [39-41] and may be indicative of region-specific differences in
neural function.
There have been few investigations of interspecific gene expression differences of the
visual cortex of primates [44, 49-51]. Khaitovich et al. [44] investigated a number of brain
regions, including V1, with the primary focus on determining the extent of region-specific
differences in expression between 3 primate species (human, chimpanzee, and macaque). These
authors found that regions of the cerebral cortex, including V1, differ significantly from other
brain regions, such as the cerebellum, and that the degree of intraspecific variation in expression
between these brain regions was significantly greater in human than chimpanzee. Furthermore,
they reported that in the cerebral cortex of both species, V1 was an outlier among other regions
investigated (dorsolateral prefrontal cortex, anterior cingulate cortex, and Broca’s area) [44].
Another study found coexpression networks specific to V1 in both humans and chimpanzees
and found the greatest degree of interspecific conservation in V1 compared to any other region
investigated [51]. The authors attributed these findings to the sensory nature of V1’s function
for which humans and chimpanzees presumably differ very little [51]. A comparison of
transcription between human, macaque, and mouse V1 using microarrays found that primate
(human and macaque) V1 expression was conserved in comparison to mouse, suggesting that
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the conserved genomic profiles of V1 extends beyond primates [49]. These studies all represent
important initial investigations of V1 gene expression, however, they largely investigate only a
few primate species (humans, chimpanzees, rhesus macaques) and emphasize other brain
regions over V1.
To understand primate visual system adaptations better at the gene expression level, we
used RNA-Seq to quantify gene expression in V1 of 13 primate species across three major
clades (hominoids, cercopithecoids, and platyrrhines), significantly increasing the number of
primates for which V1 gene expression data exists. This broad phylogenetic sampling of
phenotypically diverse primates allowed us to explore how differences in gene expression were
associated with variation in traits that contribute to a species’ visual perception, including
differences in species-typical color vision (trichromats vs polymorphic di/trichromats), and
ecological variables such as habitat use (arboreal vs terrestrial), average group size (large vs
small), and typical diet (folivore vs frugivore vs omnivore). We also evaluated the influence of
sex on gene expression in V1. We found significantly differentially expressed genes in V1
when comparing global gene expression based upon extremes in species-typical traits for color
vision, habitat use, group size and diet, but not sex. Pathway enrichment analyses of genes
exhibiting differential expression (DE) show that these expression changes correlate with
variation in visually-relevant traits, as well as expression differences between species, are
largely driven by altered metabolic signaling. Human and chimpanzee V1 expression is notably
different from other species, and though they do not differ in the visual ecological traits
investigated here, they are divergent from one another in important neurological signaling
processes.
1.3 Methods
1.3.1 Samples and Library Preparation
Tissue samples were collected from 28 individuals representing 13 primate species (n =
1-3 per species; Figure 1, SI Table 1.1). Frozen brain samples from captive adult primates free
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of known neurological disorders were obtained from various research institutions and zoos. All
individuals had been cared for according to Federal and Institutional Animal Care and Use
guidelines and died of natural causes. All tissue was collected and stored at -80°C with
postmortem intervals of less than 8 hours. Further details about the samples can be found in SI
Table 1. Due to the opportunistic nature of sampling such a phylogenetically broad group of
primates, there is unavoidable variation in age and sex of some individuals sampled (SI Table
1.1).
Each sample was dissected from the cortex of the medial aspect of the occipital pole,
surrounding the calcarine sulcus. The thin, striate cortex of V1 was visually identified in each
sample. All dissections included the grey matter of V1, extending a small extent into the
underlying white matter. Tissue samples were homogenized using a TissueLyser (Qiagen) prior
to total RNA extraction using an RNeasy Plus Mini Kit (Qiagen), including a DNase step to
remove residual DNA. Total RNA was analyzed for quality using the Agilent Bioanalyzer
system (Agilent RNA 6000 Nano kit). RNA integrity varied among our samples due sampling
from deceased primates, but there was no bias for species. Using the NEBNext Poly(A)
Magnetic mRNA Isolation Kit (NEB), mRNA was isolated from intact total RNA, and cDNA
libraries were made from each sample using the NEBNext RNA Library Prep Kit for Illumina
(NEB). Library quality was assessed using the Agilent DNA 1000 kit. Pooled samples were
sequenced using the Illumina NextSeq 500 platform to produce 75 base pair reads, yielding a
minimum of 20 million reads per sample.
1.3.2 Read Mapping and Quantification
Quality-filtered reads were aligned to available primate genomes with Bowtie2 using
default parameters for gapped alignments [52]. Current species-specific ENSEMBL genomes
were used (Homo sapiens, GRCh38.p10; Pan troglodytes, CHIMP2.1.4; Gorilla gorilla,
gorGor3.1; Pongo abellii, PPYG2; Papio anubis, PapAnu2.0; Nomascus leucogenys, Nleu1.0;
Macaca mulatta, Mmul_8.0.1; Callithrix jacchus, C_jacchus3.2.1) [53, 54]. For species for
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which there is no publicly available reference genome (Pongo pygmaeus, Symphalangus
syndactylus, Macaca nemestrina, Erythrocebus patas, Saimiri sciureus, Pithecia pithecia, and
Ateles fusciceps), reads were mapped to the closest related primate for which there was a
genome available. Specifically, M. nemestrina and E. patas reads were mapped to M. mulatta,
S. syndactylus to N. leucogenys, A. fusciceps, S. sciureus, and P. pithecia to C. jacchus, and P.
pygmaeus to P. abellii. Mapping percentages were ≥ 80% using default “—local” Bowtie2
parameters. The “—very-sensitive-local” parameter was used to increase accuracy and
alignment percentage of the samples with the lowest mapping percentages (< than 85%; 2 A.
fusciceps, 1 S. syndactylus, and 1 S. sciureus samples), and all increased to ≥ 83.5% (see SI
Table 1.1). HT-Seq [55] was used to quantify counts per gene for each sample, using
ENSEMBL gene transfer files (GTFs) corresponding to the same genome build used for
alignment [56]. For each species, homologous genes were matched to the ENSEMBL human
reference set of genes using biomaRt [57]. These were subsequently filtered to the 12,564
genes from all species that have high orthology confidence, all of which also had high homolog
percent identity to the human query genes as well as gene order conservation scores, as
previously determined by ENSEMBL [56]. This resulted in removal of genes from all
transcriptomes considered if they did not meet orthology confidence in all species. Finally, we
used the R package edgeR [58] to filter out low-expressed genes (counts per million (CPM) > 1
in 1/28 samples), resulting in 12,330 expressed orthologs in our dataset.
1.3.3 Clustering Analyses
We used clustering analyses to determine the variation in our samples. We produced a
principal coordinates analysis (PCoA) using the expression profiles of all of the protein coding
genes for each of our samples (n = 1-3 per species). To further visualize patterns within our
data, we produced phenograms by performing hierarchical clustering of the PCoA distances.
The PCoA and dendrograms show that our samples largely cluster by species and clade.
1.3.4 Differential Expression Analysis
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Differential expression (DE) analyses were performed for multiple pairwise
comparisons using a generalized linear model (GLM) in the R package edgeR (SI Table 1.2)
[58]. Normalization of data in EdgeR for DE analyses ensured that DE is not dependent on
original tissue size. Gene expression was considered significantly different at a false discovery
rate (FDR) of less than 5%. DE between species only included species for which we had more
than one sample, including human, chimpanzee, siamang, olive baboon, rhesus macaque, pigtailed macaque, patas monkey, spider monkey, and marmoset (SI Table 1.2). To determine if
there was a relationship between number of genes exhibiting DE between species, we used a
Pearson correlation between numbers of genes exhibiting DE and divergence times reported by
10k Trees of the last common branching point of the tree between the two species compared (SI
Table 1.2; [59]. The multi-factor GLM allowed us to analyze all data at once to detect DE
between species as well as between groups of samples for which the species are known to have
distinct differences in visually relevant phenotypes, data for which were collected from the
literature [10, 16, 60-63]. These species-typical data were used to label each of our samples for
color visual system (trichromats or polymorphic tri/dichromats), average group size (less than
20 individuals per group or greater than 20 individuals per group), primary diet (frugivorous,
folivorous, or omnivorous), and primary habitat (arboreal or terrestrial — mapped onto a
phylogeny in Figure 1; listed in SI Table 1.1). For each of these phenotype contrasts, all
samples of the same species-typical phenotype were grouped together and compared to the
group of samples with the opposing species-typical phenotype (e.g. all samples from primarily
frugivorous species were grouped together and compared to all samples from primarily
omnivorous species for the phenotype-DE comparison frugivorous versus omnivorous diet). DE
was also performed on each sample by sex (male or female; SI Table 1.1). Given the
comparative, discovery-based nature of our analyses, we did not correct p-values of DE genes
for the multiple interspecies or phenotype-DE comparisons, though many would have remained
significant.
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Our goal was to investigate differences in V1 gene expression between species, but also
to attempt to link V1 expression differences with differences in broad, species-level phenotypes.
It is important to note that there a number of caveats to this approach relevant to interpretation
of results. We used species-typical categories for each of the phenotypes we were interested in
correlating with V1 gene expression because we do not have the relevant phenotypic
information on each of the individuals from which our brain samples were obtained.
Importantly, our samples are from captive living animals that did not necessarily experience the
wild, ecological condition typical for their species. Thus, our study design allows us to interpret
minimal innate differences in V1 gene expression that may be related to past evolutionary
influences from visual ecological pressures, but not from dynamic experience-dependent
differences, which would probably yield even stronger signals of ecological correlations. For
these reasons, we labeled our samples for phenotype using broad, categories (e.g. primarily
arboreal species vs primarily terrestrial species rather than more discrete measurements) and we
determined DE by grouping samples by species-typical phenotype and comparing between
phenotypically distinct groups. This leads to another important caveat for our phenotype-DE
comparisons, which was that our analyses did not allow us to account for phylogeny. We
“mapped” these traits onto a phylogeny in Figure 1 to provide transparency about some of the
clear influences of phylogeny on our divergent phenotype groups. For example, the investigated
hominoid and cercopithecoid species are monomorphic for trichromatic color vision in all
individuals regardless of genotype or sex, while the platyrrhine species are polymorphic with
trichromatic homozygous females, dichromatic-males or dichromatic-heterozygous females
(Figure 1; SI Table 1.1). With these caveats in mind, we were conservative in our interpretation
of these analyses.
1.3.5 Categorical Enrichment Analysis of Differentially Expressed Genes
Genes identified as DE for each interspecies and phenotype comparison were
subsequently used for pathway enrichment with Kyoto Encyclopedia of Genes and Genomes
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(KEGG) [64] to determine differences in signaling and as well as Gene Ontology (GO) cellular
component (CC) categorical enrichment analyses [65, 66] to further determine the cellular
locality of differences. Enrichments were obtained using EnrichR with crisp data sets and
filtered by those that have an enrichment p-value less than .05 [67, 68]. To determine the most
biologically relevant enrichments, KEGG pathway enrichments were further filtered to include
only those with five or more genes per enrichment and GO CC enrichments were further filtered
to only include those with ten or more genes per enrichment. Due to the discovery-based nature
of our research question and the filtering of categories based upon gene number, we did not
restrict our analyses to only categories with significant adjusted p-values for multiple
comparisons, of which there were fewer. Similarly, GO CC enrichment terms were also grouped
into parent categories related to cellular structures (e.g., “neural cell projection”) is a larger
category containing GO CC terms such as “axon” and “dendritic branch point” which are
encompassed in the established GO CC hierarchy of “cell projections” (SI Table 1.4). The
parent category of KEGG “neuron-specific processes” includes enrichments for pathways that
are unique to the brain and the majority of these were for synaptic processes (specific
neurotransmitters, synaptic activity, and synaptic vesicle function; SI Table 1.3). Metabolic
pathways include those related to the metabolic breakdown or synthesis of all major
macromolecules, including that of carbohydrates (e.g. “glycolysis/gluconeogenesis”), lipids
(e.g., “fatty acid metabolism”), amino acids (e.g. “glycine, serine, and threonine metabolism”),
and nucleotides (e.g., “purine metabolism” ; SI Table 1.3). We report all significant categorical
enrichments (SI Table 1.3, 1.4), but in our results, largely focus on enrichments for pathways
specifically involved in neuronal and metabolic signaling, as previous work has found that these
processes exhibit DE and signatures of positive selection in cis-regulatory regions when
comparing human, chimpanzee, and rhesus macaque brains [39-41] and the importance of
metabolism in the brain provides cellular energy and critical synthesis and breakdown of
macromolecules [69-73].
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1.4 Results
1.4.1 Humans and chimpanzees exhibit the most variation in V1 gene expression
RNA-Seq was conducted on V1 tissue collected from 28 individuals from 13 primate
species, including hominoids, cercopithecoids, and platyrrhines (Figure 1, SI Table 1.1;
additional details in Methods). Despite the fact that gene expression does not evolve in the same
manner as nucleotide sequence [74], due to tissue- and cell-type-specificity within an organism,
V1 gene expression profiles overall grouped by species and phylogenetic clade (Figure 2).
Interestingly, there was greater variation in V1 transcriptomes within hominoids than
cercopithecoids or platyrrhines, predominantly due to distances observed among samples
representing human and chimpanzee (Figure 2A). Thus, the expression profiles of other
hominoids (orangutan, gorilla, and siamang) were more similar to that of cercopithecoids and
platyrrhines than to human and chimpanzee (Figure 2A). Hierarchical clustering of whole
transcriptomes revealed similar results, with most samples per species clustering generally
according to phylogeny (Figure 2B). The exceptions were for the single representative samples
of gorilla, saki monkey, squirrel monkey, and orangutan. Additionally, the two pig-tailed
macaque samples clustered away from the other cercopithecoid species. These multivariate
analyses indicate conservation in the overall expression profiles of primates with the exception
of human and chimpanzee. There are no overt technical factors influencing the out grouping of
human, chimpanzee, or pig-tailed macaque samples (e.g. individual sex or age, sample
hemisphere of origin, RNA or cDNA library quality, read number, alignment percentages, SI
Table 1.1). Our finding of human and chimpanzee divergence from other species is consistent
with other studies [38, 41, 47, 48] and highlights that the increased distinctiveness of brain
gene expression with proximity to the human lineage extends to V1.
Next, we performed pairwise differential expression (DE) analyses between species to
determine the proportion of genes that were statistically significantly differentially expressed
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(SI Table 1.2). There was a positive correlation between number of genes exhibiting DE and
phylogenetic distance (r = 0.6, p = 0.0001, Pearson correlation), demonstrating that the number
of genes exhibiting DE increases with phylogenetic distance (SI Table 1.2). However, humans
exhibit noticeably greater numbers of genes displaying DE when compared to chimpanzee (n=
3,648) and siamang (n= 3,846; SI Table 1.2), despite being relatively closely related. Notably,
chimpanzee and siamang do not exhibit as high a degree of difference from one another (n=
2,771; SI Table 1.2). This may suggest that there is significant difference in V1 expression with
phylogenetic proximity to humans, and not more generally in the hominoid clade. These results
demonstrate that there is a significant degree of DE in V1 across primate species, despite its
sensory function.
1.4.2 Metabolic and neuronal signaling are enriched in V1 DE
To determine what biological processes are enriched in genes displaying DE in V1, we
performed pathway enrichment analyses for Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway terms of pairwise DE comparisons (Table 2; SI Table 1.3). To obtain an
overall view of global processes enriched in primate V1 DE, we grouped specific pathways into
broad parent KEGG categories for “signaling”, “immune”, “disease”, “neuron-specific”,
“metabolic”, and “other”, generally following the established hierarchy already present in the
KEGG ontology (SI Table 1.3; for more details on thresholding and grouping of pathways into
parent categories, see Methods). Overall, there was a wide variety of KEGG pathways enriched
in these DE comparisons related to inter- and extracellular signaling processes associated with
growth and development, as well as more specific pathways related to cellular metabolism (e.g.
glycolysis) and neuron-specific signaling (e.g. synaptic signaling; SI Table 1.3). To assess
whether metabolic and neural processes routinely differ in the gene expression of primate V1,
as well as what interspecies DE comparisons deviated from that trend, we determined what
proportion of all the pathways enriched were metabolic or neuron-specific signaling pathways.
On average, metabolic pathways accounted for 23.8% of enrichments while neural pathways
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only accounted for 7.6% of enrichments (SI Table 1.3). Similarly, enrichments for metabolism
were present in all interspecies DE comparisons (34/34 pairwise species comparisons), while
enrichments for neuron-specific processes were present in only 23/34 comparisons (SI Table
1.3). Interestingly, there was a reduction in the proportion of metabolic enrichments observed in
the human-chimpanzee DE comparison coinciding with an increase in the number of neuronspecific enrichments (Table 1; SI Table 1.3).
Synaptic signaling pathways included in the neuron-specific parent group of enriched
pathways included glutamatergic, cholinergic, serotonergic, and GABAergic synaptic signaling
as well as “synaptic vesicle cycling” and “long-term potentiation” (SI Table 1.3). Other neuronspecific KEGG pathways that were enriched included axon guidance, neurotrophin signaling,
and oxytocin signaling (SI Table 1.3). All eight DE comparisons of chimpanzee to other species
had higher proportions of neuron-specific pathway enrichments of any interspecies DE
comparison (SI Table 1.3). The DE comparison between human and chimpanzee had the most
neuron-specific enrichments of any interspecies DE comparison (n =12; SI Table 1.3), including
cholinergic and GABAergic synapse among the top ten most significantly enriched pathways (p
< 0.0001; Table 1). In contrast, there were no neuron-specific pathways enriched in the top ten
KEGG pathways for any other human interspecies DE comparisons (except neuroactive ligand
receptor interaction in the DE comparison between human and siamang; Table 1). These results
highlight that differences in neuron-specific processes in the V1 are not common across all
primates but are more prominent with proximity to human, and most notably between human
and chimpanzee.
The V1 region is highly specialized in cytoarchitecture and structure [15], and previous
studies have determined that many of the V1-specific differences in gene expression between
species are for genes involved in determining this structure [49]. Therefore, in addition to
KEGG pathway enrichments, we conducted pathway enrichment analyses for Gene Ontology
(GO) cellular components (CC) for pairwise DE comparisons to determine if there were
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differences in primate V1 related to specific neuron cellular parts. In many interspecific
comparisons, including, but not limited to human vs. chimpanzee, there were several GO CC
enrichments related to plasma membrane-associated complexes of known importance for
intercellular signaling in the brain, including ATP-coupled ion channels and various
neurotransmitter plasma membrane receptors and intermembrane transporters “clathrin-sculpted
glutamate transport vesicle membrane”, “ionotropic glutamate receptor complex”, and “ciliary
neurotrophic factor receptor complex” (SI Table 1.4). There were also enrichments for GO CC
terms for specialized cell projections that characterize neural cells, including components of
dendrites (e.g. dendritic branch point) and types of axons (“C fiber”), as well as for synapse
parts and neurofilaments (SI Table 1.4). Interestingly, DE comparisons between human and
chimpanzee and other species are the only interspecies DE comparisons to be enriched for
dendrite cellular parts and only chimpanzee DE comparisons are enriched for axon cellular parts
(SI Table 1.4). Enrichments for GO cellular components corroborate KEGG pathway
enrichments and further show that neural signaling complexes critical for neurological signaling
and structure, such as plasma membrane associated channels, dendrites, and axons, differ
among primate V1.
To determine how metabolic gene expression differed from global gene expression in
primate V1, we subset our expression matrix to include only genes involved in metabolic
KEGG pathways (n = 1039, Figure 3). When we generated a heatmap where species clustered
based upon distance between expression values, we saw that expression profiles of metabolic
genes result in clustering of species according to clades: all platyrrhines, hominoids, and
cercopithecoids group together with no overt pattern in the metabolic KEGG pathways to which
the genes belong (bottom color-coded bar, Figure 3). This demonstrates that while there are
significant differences in metabolic gene expression in primate V1, species-specific metabolic
patterns still seem to contain substantial phylogenetic signal. To try to elucidate what metabolic
processes distinguish each clade, we identified which pathways demonstrated DE between
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species of different clades, but not between species belonging to the same clade. Carbohydrate
metabolism appears to be the most distinguishing set of metabolic pathways between clades.
Hominoids differ from platyrrhines in citrate (TCA) cycle gene expression and differ from both
cercopithecoids and platyrrhines for glyoxylate and decarboxylate metabolism (SI Table 1.3). In
contrast, platyrrhines differ from both cercopithecoids and hominoids for amino sugar
metabolism and glycolysis/gluconeogenesis gene expression (SI Table 1.3). One noticeable
exception of a carbohydrate metabolic pathway that differed consistently between species’
comparisons of all three cross-clade combinations but never between two species of the same
clade was fructose and mannose metabolism, which displayed DE between 13 interspecies
comparisons, including six comparisons of cercopithecoids to platyrrhines, five comparisons of
hominoids to cercopithecoids, and two comparisons of hominoids to platyrrhines (SI Table 1.3).
Taken together, these results show that metabolic changes in primate V1 are common across
primate species in a manner consistent with phylogeny and that the metabolic gene expression
differences influencing this are primarily related to carbohydrate metabolism. In summary,
variation in primate V1 gene expression is not limited to neural signaling processes and in fact
seems to be driven to a large extent by altered metabolic signaling, although neural signaling
appears to contribute more to differences in expression with proximity to humans.

1.4.3 Visual cortex DE is correlated with differences in color vision, group size, diet, and
habitat use
We leveraged the wealth of phenotypic and behavioral data available for the sampled
primate species to help understand correlations between V1 gene expression and variation in
species-typical color vision, habitat use, diet, group size, and individual differences in sex
(summarized in Figure 1; details in Methods and SI Table 1.1) [10, 16, 60-63]. These
phenotype-DE comparisons were conducted by grouping all samples according to the speciestypical state of their color visual system (trichromats or polymorphic di/trichromats), habitat use
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(primarily arboreal or terrestrial), generalized diet (primarily frugivorous, folivorous, or
omnivorous), and group size (primarily living in small or large groups) and determining genes
exhibiting DE between the phenotype-extremes. We reasoned that this would be a fairly
conservative estimate of differential expression because the grouping of such disparate species
likely introduces far more variability (“noise”) than when comparing two discrete species and
results in far fewer numbers of genes exhibiting DE in these phenotype comparisons. Of these
trait-based DE comparisons, we detected DE based upon differences in color visual system,
primary habitat use, group living size, and primary diet (frugivore-folivore, folivore-omnivore,
frugivore-omnivore) but not sex in the samples used for this study (Table 2, SI Table 1.2). The
highest proportion of trait-based DE was for differences in color vision (25.3%) and the lowest
was for the diet-based comparisons (4.3-7.9%; Table 2, SI Table 1.2). While many of the parent
categories of pathways were enriched in all phenotype-DE comparisons, there were unique
enrichments for specific pathways depending on the phenotype compared (Table 3). It is
important to note that for some traits investigated here that there is a clear influence of
phylogeny on differences in phenotype based purely on the species for which we have samples
(further discussed in Methods). Because we cannot parse out how much this influences the
phenotype-DE comparisons, we are conservative in our interpretations of these analyses.
Color vision has long been hypothesized to be adaptive in primates with numerous
complementary and competing hypotheses about the pressures influencing its evolution
(reviewed in [24]. When comparing expression between species that differ in color vision,
25.3% (n = 3173) of genes displaying DE (Table 2; SI Table 1.2). For our samples, the
investigated hominoid and cercopithecoid species are monomorphic trichromats in all
individuals, while the platyrrhine species are polymorphic with trichromatic homozygous
females, dichromatic males or dichromatic heterozygous females (Figure 1; SI Table 1.1).
However, despite color vision being sexually dimorphic in some of the platyrrhine species, very
few genes were significantly differentially expressed in V1 between sexes (0.28% DE, n = 35;
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Table 2; SI Table 1.2). There were no neuronal-specific KEGG signaling pathways enriched in
genes displaying DE between trichromatic species and polymorphic di/trichromatic species but
there were a number of metabolic pathways enriched, including amino acid, nucleotide,
glycolysis/gluconeogenesis, and sphingolipid metabolic pathways (SI Table 1.3). Notably,
color vision was the only phenotype-DE comparison enriched for the encompassing, large
KEGG pathway of “metabolic pathways” and “carbon metabolism” and included 226 genes (SI
Table 1.3). This is 8-fold more genes than any other KEGG pathway enrichment, suggesting
that there are extensive metabolic differences in the V1 of primates differing in color vision.
However, given the clear phylogenetic influence on these samples (Figure 1, SI Table 1.1), we
cannot resolve whether these differences are truly due to divergent color visual perception or
rather how hominoids and cercopithecoids differ from platyrrhines in V1.
We investigated DE between primarily arboreal and terrestrial species due to the role of
V1 in processing signals derived from navigating and perceiving the environment [15]. The
primarily arboreal species in our study included all four platyrrhine species and two hominoid
species (orangutan and siamang) while the primarily terrestrial species included all four
cercopithecoid species and three hominoid species (human, chimpanzee, and gorilla; Figure 1,
SI Table 1.1). There were 2,501 genes with DE in V1 associated with differences in primate
habitat use (either arboreal or terrestrial; 19.9%, Table 2; SI Table 1.2). Neural KEGG pathways
enriched in species differing in habit use included neuroactive ligand receptor interaction, longterm depression, and retrograde endocannabinoid signaling (SI Table 1.3). This phenotype DE
comparison was enriched primarily for lipid metabolic pathways (SI Table 1.3). Lipids are
important in the brain for long-term energy storage, membrane structure, extracellular signaling,
and enhanced propagation of neural signaling (e.g. myelination) [75]. Habitat use DE
enrichments for lipid metabolism may suggest that these processes differ significantly in V1 as
it responds to visual stimuli from divergent interactions with habitat, such as enhanced V1
processing of depth perception for arboreal versus terrestrial species.
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We also explored possible expression differences in V1 that correlate with differences
in sociality, using group size as a proxy variable. For the included species, the “small group”
included three platyrrhines species (spider monkey, marmoset, and saki monkey), and three
hominoid species (siamang, gorilla, and orangutan) with fewer than 20 individuals per group on
average and the “large group” included all four cercopithecoid species, one platyrrhine species
(squirrel monkey) and two hominoid species (human and chimpanzee) with greater than 20
individuals per group, on average (Figure 1, SI Table 1.1). We found that 13.6% (n = 1704)
genes exhibited DE between species that differed in group size (Table 2; SI Table 1.2).
Categorical enrichment determined genes displaying DE between species differing in group size
had more neural processes enriched than any other DE comparison based upon trait except for
diet (see below), including neuroactive ligand receptor interaction, long-term depression,
retrograde endocannabinoid signaling, and GABAergic synapse (SI Table 1.3). Of the genes
exhibiting DE between large and small group living species, metabolic KEGG enrichments
included amino acid sugar and nucleotide sugar metabolism and fatty acid degradation (SI
Table 1.3). Because both long-term depression and GABAergic synaptic signaling function in
inhibitory signaling [76], enrichments for both of these processes may suggest a significant
difference in inhibitory signaling in the V1 among primates differing in group size, which may
be due in part to differential visual responses necessary for navigating socially complex
environments.
To compare V1 expression between species that differ by diet, we categorized our
species as primarily frugivorous, primarily folivorous, or omnivorous [63]. The primarily
frugivorous species included two hominoid species (chimpanzee and orangutan) and three
platyrrhine species (spider monkey, marmoset, and saki monkey) while we had two primarily
folivorous hominoid species (gorilla and siamang; Figure 1, SI Table 1.1). The omnivorous
species included all four cercopithecoid species, a single platyrrhine species (squirrel monkey)
and a single hominoid species (human; Figure 1, SI Table 1.1). We calculated DE among the
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three possible comparisons: folivore-frugivore (4.3% DE, n = 534), folivore – omnivore (5.3%,
n = 664), and frugivore – omnivore (7.9%, n = 991; Table 2; SI Table 1.3). Folivorous species
differed from omnivorous species in in tryptophan, purine, and steroid metabolic KEGG
pathways (SI Table 1.3). Folivorous species differed from frugivorous species in carbohydrate
and protein digestion and retinol and tryptophan metabolism (SI Table 1.3). Frugivorous
primates displayed much higher numbers of genes exhibiting DE in V1 than frugivore-folivore
and folivore-omnivore comparisons, though this may be due to a lack of folivorous species in
the available samples (only siamang and gorilla were folivorous; Figure 1; SI Table 1.2).
Frugivorous-omnivorous DE was enriched for serotonergic synaptic signaling and was the only
diet comparison enriched for any neuron-specific KEGG pathways (SI Table 1.3). Frugivores
differed from omnivores metabolically for amino acid metabolism (SI Table 1.3). Given that
serotonin levels have an established link to diet [77] and tryptophan is a known precursor for
serotonin [78], the finding that both tryptophan and serotonergic signaling are only enriched in
DE between species differing in diet may suggest that diet has an impact on V1 serotonin
signaling by way of altered tryptophan metabolism.
All trait DE comparisons were enriched for at least one pathway in the metabolic parent
categories but not for neural signaling (SI Table 1.3). Our results suggest that neural processes
drive differences in V1 gene expression in species that differ in group size, habitat use, and diet
while metabolic differences are more responsible for V1 DE between species differing in color
vision (SI Table 3). Our approach correlating DE with phenotype suggests that there is a link
between expression in V1 and distinctive differences in visually relevant traits.

1.5 Discussion
Although some studies of V1 gene expression compared it both to other regions of the
brain, as well as across species [44, 49-51], no other investigations of brain gene expression
included nearly the diversity and number of primate species in the current study. As such, this

29

represents one of the first in-depth investigations of how V1 gene expression differs across a
variety of primate species. We found that while global gene expression in primate V1 clusters
largely by phylogenetic relatedness, the greatest degree of variation in expression is within
hominoids, largely due to divergence of humans and chimpanzees from other one another as
well as other hominoid species. Carbohydrate metabolic processes seem to be driving
expression differences across the primate tree while neural processes are more conserved in V1.
A deviation from this trend is the expression differences between human and chimpanzee.
These species are outliers from all other species and display a relatively large amount of
intraspecific variation in global gene expression profiles as well as in specific pathways related
to synaptic signaling and neuronal cell projections important for maintaining the complex
neurological signaling networks key to brain function. In addition to global and interspecific
differences in expression, we were able to link V1 DE to differences in visually-relevant
phenotypes.
The enrichment for neuron-specific processes in V1 DE, primarily between human and
chimpanzee, is consistent with previous findings of enrichments for similar processes, such as
synaptic signaling, in differential gene expression that have been reported in various studies of
human, chimpanzee, and rhesus macaque brains [39-41]. Also, similar metabolic processes as
those enriched here have also been found to differentiate primate brain gene expression in a
number of previous studies of a smaller array of primate species [43, 44, 49, 79], including that
humans specifically differ largely in metabolic processes related to aerobic glycolysis [40, 41].
Taken together, our results across a broad number of primate species show that these trends for
metabolic and neural signaling differences in the brain extend to V1.
Given that V1 is a primary sensory cortex and in view of subtle interspecies differences
in visual perception between closely related primates, there might not be much divergence
expected over shorter evolutionary times. Consistent with this, we found a significant
correlation for greater numbers of genes exhibiting DE between more distantly related species.
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Our finding that interspecies DE tends to increase with evolutionary distance has been observed
previously in a study of gene expression across ten species (including six hominoids) and six
tissue types [45]. Furthermore, we observed a trend for genes involved in metabolic signaling to
be differentially expressed consistently across interspecies DE comparisons, regardless of
phylogenetic distance, while processes specific to neural signaling were far less common.
Because the most metabolically demanding feature of the brain is synaptic transmission,
metabolic differences are not mutually exclusive with neural signaling processes, but this is an
interesting trend nonetheless. Our findings suggest that altered gene expression of neuronspecific pathways in V1 does not consistently contribute to functional differences between
closely-related species, but altered metabolic processes do (e.g. oxidative phosphorylation is
enriched in genes exhibiting DE between all cercopithecoid species; SI Table 1.2). The
exception to this is that neuron-specific processes were among the most significantly enriched
pathways in genes exhibiting DE between human and chimpanzee.
Within primates, selective differences in the genome can be linked to diet and
metabolism, suggesting selection has optimized different metabolic processes in lineagedependent ways [39-41, 80-83]. The human brain is more energetically costly than that of other
primates, utilizing ~ 20% of all of the body’s metabolic resources, in comparison to non-human
primate brains that use less than 10% [84, 85]. Importantly, allometry alone does not explain the
increase in human brain appropriation of glucose metabolism at this proportion [86-88]. Our
results are consistent with previous findings that humans differ in brain gene expression from
chimpanzees for neuron-specific processes related to synaptic transmission and metabolic
processes involved in aerobic glycolysis [40, 41, 43, 44, 49, 79]. These data demonstrate that,
like other brain regions [38, 41, 47, 48], human lineage-specific neurological changes are
present in the visual cortex.
Understanding V1 gene expression differences based upon variation in phenotypes
relevant for vision is an area of research that could elucidate the neurological implications of
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differences in vision and the selective pressures hypothesized to be linked to these traits.
Although there are important caveats to our analysis of phenotype-based DE, primarily an
inability to account for phylogenetic influences (see Methods for more details), this still
represents a significant effort to link proximate gene expression differences in the brain with
evolved variation in ecological traits. DE among species differing in color vision was enriched
for a number of metabolic processes but not neural signaling processes, perhaps suggesting that
any expression differences in V1 influenced by differences in color visual perception are driven
more by metabolic differences than by those of synaptic signaling. However, this phenotype-DE
comparison has the strongest influence of phylogeny, and we are not able to parse out if this
difference represents that of divergent color perception or a difference between platyrrhines and
cercopithecoids and hominoids.
Furthermore, we chose to investigate the link between group size differences and V1
gene expression due to the hypothesized influences of social behavior on primate brain
evolution and the possible link to required differences in visual perception among group living
primates [25]. While V1 is not explicitly involved in behavioral processes, there were
enrichments for pathways known to be involved in behavior. Primates exhibit extensive
variation in social traits, and a number of genes (and associated pathways) have been
hypothesized to be linked to these behaviors, such as those involved in social bonding or
empathy [arginine vasopressin receptor 1A (AVPR1A), oxytocin receptor (OXTR), and
dopamine receptor (DRD4)] [89]. Oxytocin signaling changes in response to social interactions
is well documented [90, 91] and variations in coding sequence for oxytocin receptor and their
associated influence on social behavior have been observed in rhesus macaques [92]. While
group size was not enriched for “oxytocin signaling pathway” or “dopaminergic synapse”, the
genes DRD4 and OXTR were both differentially expressed in the DE comparison of species
differing in group size, alternatively included in the enriched category “neuroactive ligand
receptor interaction” (SI Table 3). Our results show that genes putatively important in primate
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social evolution and associated processes display significant DE in V1 in primates differing in
group size.
Future studies comparing multiple brain regions may determine if the observed trends
of altered gene expression between phenotypically distinct primates and between species are
V1-specific or a brain region-independent observation. However, the phenotypes investigated
here (color vision variation, arboreality and terrestrially, group size and sociality, and diet) do
not have implications solely for primate vision evolution and thus are not expected only to
impact on visual cortex gene expression evolution and have likely played important roles in
other brain regions, and perhaps the brain overall. Additionally, the hypothesized importance of
the evolutionary trajectories of these phenotypes are not mutually exclusive of one another - it is
most likely that the evolution of trichromatic color vision has been influenced by an interplay of
diet, arboreality, social signals, and other important primate traits. Because our methods could
not resolve the influences of each of these traits on V1 gene expression evolution, we remained
conservative in our interpretations of the link between phenotype evolution and gene expression
evolution. Furthermore, given the highly organized and specific cytoarchitecture of the V1 [15],
and previously determined influence of structural genes on V1-specifc gene expression in
comparison to other regions [49], it is possible that V1-region specific changes in gene
expression are linked to maintaining or fine-tuning this cytoarchitecture. However, studies of
V1 function are largely limited to tissue-level functional, mechanistic, and cytoarchitectural
investigations [93-95] and primarily only in rhesus macaques, resulting in a very limited
understanding of the gene expression changes that accompany altered systems-level function.
This, in addition to the lack of other brain regions for comparison in our current study across
such disparate primate species and the previous findings that V1 gene expression is similar to
other brain regions except cerebellum in a limited number of primate species (rhesus macaque,
chimpanzee, human) [44], we limit our conclusions about V1 region-specific gene expression
and its link to variation in visually relevant phenotypes.
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1.6 Conclusion
We investigated the interaction between genotype and phenotype by examining the
correlation between gene expression and phenotypic and behavioral traits, including habitat use,
color visual system, group size, and diet in a broad sampling of primate species, including many
understudied species (e.g. siamang, squirrel monkey, and spider monkey). We determined that
neural and metabolic processes known previously to differ between species in other brain
regions also demonstrate interspecies and trait-based differences in V1. We show that human
and chimpanzee are outliers for V1 gene expression, differing significantly more in neuronspecific processes related to synaptic signaling than other species do. Although these species
appear to be the most divergent, they do not exhibit any major differences in the visuallyrelevant phenotypes investigated here for which we were able to determine significant
expression differences. Future studies that include other primate taxa could further investigate
the link between differences in primate vision evolution and visual cortex expression
differences.
As primates exhibit many unique visual system traits compared to other mammals and
understanding the genetic basis for primate visual systems in the V1 region would provide
valuable insights into the evolutionary trajectory of these traits. Our data indicate that there is
also a correlated difference in gene expression in the initial processing center of visual signals
in the brain. We also show that humans differ in brain gene expression in the V1 in a manner
similar to other regions. Further investigation of overlap between DE and signals of selection
can provide information about which expression changes are adaptive.
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1.7 Supplemental Table List
Table Name
Supplemental Table 1.1

Content
Sample-specific information.

Supplemental Table 1.2

Full table of numbers of genes exhibiting DE for all
pairwise DE comparisons.

Supplemental Table 1.3

Kyoto Encyclopedia of Genes and Genomes (KEGG)
Enrichments for each pairwise DE comparison. All
pathways enriched are significant (p<.05) and include
5 or greater genes. Specific KEGG term, ID number
and parent group are listed.

Supplemental Table 1.4

Gene ontology (GO) cellular component (CC)
enrichments for each pairwise DE comparison. All
CC's are significant (p<.05) and contain 10 or greater
genes. Specific CC terms, IDs, and parent group are
listed.
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1.8 Figures and Tables
Figure 1
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Figure 1 | Phenotypic traits of species for which V1 gene expression was investigated.
Phenotypic traits for color vision, habitat use, and group size are mapped on the phylogeny and
diet is depicted to the right of species names. Species without a diet indicator were coded as
omnivorous. The tree was generated using 10k Trees Version 3 [59] and Mesquite [96].
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Figure 2
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Figure 2 | Humans and chimpanzees are the most divergent in V1 gene expression. A) principal
coordinate analyses (PCoA) of V1 transcriptomes color-coded by species. Shapes of points
indicate clade: triangles for hominoids, squares for cercopithecoids, and circles for platyrrhines.
B) Hierarchical clustering of V1 transcriptomes of each sample with bootstrap values and the
individual sample number in brackets.
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Figure 3
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Figure 3 | Expression profiles of metabolic genes in primate V1. Clustering of expression
profiles of 1,039 metabolic genes in primate V1. Highly correlated genes (columns) cluster
together and samples (rows) cluster based on Euclidean distance between expression values.
Only species for which there were greater than one sample per species were used. Averages of
expression per gene were calculated across replicates per species. The bottom bar represents
membership in the color-coded KEGG metabolic pathways for each gene in the heatmap.
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Table 1
Interspecies-DE Comparison
Human Human Human Human Human Human Human Human Human Human Human Human Human Human -

Chimpanzee
Chimpanzee
Siamang
Siamang
Baboon
Baboon
Rhesus macaque
Rhesus macaque
Rhesus macaque
Marmoset
Marmoset
Spider monkey
Spider monkey
Spider monkey

KEGG Term

KEGG Parent Category

Cholinergic synapse
GABAergic synapse
Neuroactive ligand receptor interaction
Metabolic pathways
Metabolic pathways
Fatty acid metabolism
Steroid biosynthesis
Purine metabolism
Nicotinate and nicotinamide metabolism
Metabolic pathways
Nicotinate and nicotinamide metabolism
Metabolic pathways
Steroid biosynthesis
Purine metabolism
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Synaptic Signaling
Synaptic Signaling
Neuronal Signaling
General Metabolism
General Metabolism
Lipid Metabolism
Lipid Metabolism
Nucleotide Metabolism
Cofactor & Vitamin Metabolism
General Metabolism
Cofactor & Vitamin Metabolism
General Metabolism
Lipid Metabolism
Nucleotide Metabolism

# Genes
40
31
75
272
364
20
11
55
13
349
15
326
11
54

Enrichment P-Value
P-value
Rank
0.00001
1
0.00011
4
0.00086
3
0.00730
9
0.00001
1
0.00558
7
0.00118
5
0.00206
7
0.00465
10
0.00046
3
0.00122
6
0.00024
1
0.00142
3
0.00549
7

Table 1 | Metabolic pathways are the most significantly enriched in interspecies DE
comparisons with the exception of human-chimpanzee. A table of the top-10 most significantly
enriched KEGG pathways in interspecies DE comparisons between human and other species,
abbreviated to show only metabolic (green) and neuron-specific (purple) pathways. ‘# Genes’
refers to the number of genes exhibiting DE in that pathway. P-value rank refers to the rank of
the enrichment within the top 10 for each comparison. Table is sorted by interspecies DE
comparison. Abbreviated from SI Table 3.
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Table 2
Phenotype-DE Comparison
Color vision
Habitat-use
Group-size
Folivore-frugivore
Folivore-omnivore
Frugivore-omnivore
Sex

# Genes % Genes
3173
25.25
2501
19.91
1704
13.56
534
4.25
664
5.28
991
7.89
35
0.28
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Table 2 | Proportions of DE genes in primate species V1 vary depending on the compared
phenotypes. Pairwise list of phenotype-based DE comparisons. ‘# Genes’ refers to the number
of genes exhibiting DE in that pathway. This is a subset of all comparisons made, see SI Table 2
for the full list of genes exhibiting DE for all comparisons. Abbreviated from SI Table 2.
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Table 3
Phenotype-DE Comparison
Metabolic Pathways
Color vision
Diet: frugivore -omnivore
Group size
Color vision
Diet: frugivore - folivore
Color vision
Diet: folivore - omnivore
Group size
Habitat Use
Habitat Use
Habitat Use
Color vision
Diet: folivore - omnivore
Neuron-Specific Pathways
Diet: frugivore -omnivore
Diet: frugivore -omnivore
Group size

KEGG Parent Category

# Genes

Enrichment
P-value

Biosynthesis of amino acids
Glycine serine and threonine metabolism
Histidine metabolism
Glycolysis Gluconeogenesis
Retinol metabolism
Sphingolipid metabolism
Steroid hormone biosynthesis
Fatty acid degradation
alpha Linolenic acid metabolism
Ether lipid metabolism
Glycerophospholipid metabolism
Pyrimidine metabolism
Purine metabolism

Amino Acid Metabolism
Amino Acid Metabolism
Amino Acid Metabolism
Carbohydrate Metabolism
Cofactor & Vitamin Metabolism
Lipid Metabolism
Lipid Metabolism
Lipid Metabolism
Lipid Metabolism
Lipid Metabolism
Lipid Metabolism
Nucleotide Metabolism
Nucleotide Metabolism

21
5
6
17
5
13
6
8
7
11
20
26
12

0.004
0.046
0.013
0.030
0.030
0.028
0.012
0.031
0.030
0.020
0.013
0.012
0.015

Serotonergic synapse
Synaptic vesicle cycle
GABAergic synapse

Synaptic Signaling
Synaptic Signaling
Synaptic Signaling

12
8
14

0.010
0.012
0.016

KEGG Term
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Table 3 | Some KEGG pathway enrichments in phenotypic-DE comparisons are not enriched in
more than one phenotype-DE comparison. “Uniquely enriched” KEGG terms are shown for
each phenotype-DE comparison investigated. KEGG parent categories do overlap, with the
exception of “Cofactors & Vitamins”. ‘# Genes’ refers to the number of genes exhibiting DE in
that pathway. Abbreviated from SI Table 3.
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CHAPTER 2

CHIMPANZEE FIBROBLASTS EXHIBIT GREATER ADHERENCE AND
MIGRATORY PHENOTYPES THAN HUMAN FIBROBLASTS

2.1 Abstract2
Background and objectives: Previous work has identified that gene expression differences in
cell adhesion pathways exist between humans and chimpanzees. Here, we used a comparative
cell biology approach to assay interspecies differences in cell adhesion phenotypes in order to
better understand the basic biological differences between species’ epithelial cells that may
underly the organism-level differences we see in wound healing and cancer.
Methodology: We used skin fibroblast cell lines from humans and chimpanzees to assay cell
adhesion and migration. We then utilized published RNA-Seq data from the same cell lines
exposed to a cancer / wound-healing mimic to determine what gene expression changes may be
corresponding to altered cellular adhesion dynamics between species.
Results: The functional adhesion and migration assays revealed that chimpanzee fibroblasts
adhered sooner and remained adherent for significantly longer and move into a “wound” at
faster rate than human fibroblasts. The gene expression data suggest that the enhanced adhesive
properties of chimpanzee fibroblasts may be due to chimpanzee fibroblasts exhibiting
significantly higher expression of cell and focal adhesion molecule genes than human cells, both
during a wound healing assay and at rest.

This chapter is formatted for publication in Evolutionary Medicine and Public Health
with a planned submission date sometime in November 2019. The full author list for
this manuscript is: Trisha M. Zintel, Delaney Ducey, Alyssa D. Schwartz, Courtney C. Babbitt
2
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Conclusions and implications: Chimpanzee fibroblasts exhibit stronger adhesion and greater cell
migration than human fibroblasts. This may be due to divergent gene expression of focal
adhesion and cell adhesion molecules, such as integrins, laminins, and cadherins, as well as
ECM proteins like collagens. This is one of few studies demonstrating that these divergences in
gene expression between closely related species can manifest in fundamental differences in cell
biology. Our results provide better insight into species-specific cell biology phenotypes and
how they may influence more complex traits, such as cancer metastasis and wound healing.
2.2 Introduction
Although humans and chimpanzees shared a common ancestor relatively recently (~ 5
million years ago), they have largely identical amino acid and protein structure and greater than
98% DNA sequence identity [37, 97]. Despite this high nucleotide conservation, there are many
well-documented phenotypic discrepancies related to cognition, behavior, and anatomy,
including some intriguing differences that may be biomedically relevant for understanding
human-specific disease [97, 98]. Determining specific genetic influences on interspecies
disparities in disease etiology is important to understand human-specific diseases [99, 100]. In
order to better understand these organism-level differences in complex phenotypes, and their
evolutionary basis, we can investigate interspecies differences in basic molecular and cellular
biological processes.
One mechanism by which interspecies differences in phenotype may arise from highly
similar genomes is through changes in non-coding sequences that influence the expression the
same protein-coding genes [37]. Significant changes in gene expression between humans and
chimpanzees have been studied previously [38-42, 44-46, 101]; however, studies of the cellular
phenotypic impacts of altered gene expression are lacking. One way to start to make those
connections is to use available cell lines from multiple species. Fibroblast cells are important for
homeostasis and critical for wound healing and often play an integral role in inflammation
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during cancer progression [102, 103]. A previous publication found that chimpanzee skin
fibroblasts have significantly more focal adhesions per cell than human fibroblasts [104].
Additionally, human and chimpanzee fibroblasts exhibit significant differences in gene
expression of adhesion pathways both in fibroblasts grown under normal conditions [101, 105]
as well as those exposed to a serum challenge that mimics both wound healing and a cancer
response [105]. However, there are no known studies investigating if these differences influence
cellular adhesion and migratory phenotypes.
Intercellular signaling facilitated by cell adhesion is vital for many biological processes,
such as embryonic development as well as disease states (e.g. metastasis of cancerous cells) and
consequently represents a potential mechanism by which functional differences among primates
may have evolved. Healing of a wound in vivo requires migration of neighboring healthy cells
into the wound [106] which is facilitated by disassembly and reassembly of focal adhesion
complexes to the leading edge of migrating cells [107-110]. Cell adhesion and migration
pathways are important in a number of complex traits, including development and
differentiation [110-113] as well as cancer metastasis [114-117]. Focal adhesions (FAs) are
large protein complexes that facilitate adhesion of cells to the underlying extracellular matrix
(ECM) as well as cell motility by the disassembly and reassembly of these complexes in
difference locations along the cell’s adherent surface [107-110, 118]. A variety of protein
types comprise FAs, including extracellular protein complexes (e.g. zyxin) that interact
extracellular matrix proteins (e.g. collagen, laminin) to facilitate adherence as well as
transmembrane proteins that function not only in adherence but also in bidirectional signaling
across the membrane (e.g. vinculin, integrin) [107].
In order to determine if previous findings of interspecies differences in adhesion
complexes and gene expression translate into fundamental differences in cellular phenotypes,
we used established cell culture methods to assay adhesion and migration differences between
human and chimpanzee primary skin fibroblasts in vitro. We hypothesized that there may be
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significant differences in cellular adhesion and migration phenotypes between human and
chimpanzee fibroblasts that correlate with the previously observed differences in focal adhesion
gene expression. We investigated adhesive properties using two different cell adhesion assays,
that measured timing and strength of fibroblast adherence and migration phenotypes by
comparing migration patterns, speed, and distance of cells over time in two conditions. We also
used a classic scratch test that mimics a wound and the subsequent healing process in vitro [119,
120]. Finally, in order to examine underlying gene expression differences in adhesion and
migration signaling pathways between species at the cellular level, we incorporated previously
published data on differential gene expression between human and chimpanzee fibroblasts
during an assay that mimics both wound healing and cancer progression [105].
2.3 Methodology
2.3.1 Samples
Primary fibroblasts from two individuals per species were obtained from Coriell
Biorepository (Camden, NJ) (human lines AG10803 and AG09605, chimpanzee lines S006007
and S008956). Cells were cultured with minimum essential media (MEM) supplemented with
10% fetal bovine serum (FBS), 1% L-glutamine, & .1% antibiotic at 37C and 5% CO2,
according to Coriell protocols. Cells were sex-, age-, and body-region- matched.
2.3.2 Cell adhesion assay
Fibroblasts at 80-90% confluency in 6-well plates were dyed with a non-toxic
cytoplasmic dye for ten minutes at a concentration of 1 µM (CellTracker, catalog #C7025,
Invitrogen). A live cell nuclear stain was then added for twenty minutes, according to
manufacturer’s instructions (NucBlue, #R37605, Invitrogen). Fibroblasts were subsequently
passaged using .5% trypsin and seeded as evenly as possible into eight individual wells of a 12well plate. At four timepoints (.5, 1, 1.5, 2 hours), wells were rinsed to remove non-adherent
cells and fluorescent images were taken. To maximize accurate counts of cells/well, each well
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was divided into two quadrants, and for each timepoint, one photo per quadrant was taken. Cell
counts were obtained using FIJI Is Just ImageJ (FIJI) [121] to quantify the fluorescently dyed
cells. We calculated a mean of the two counts per timepoint. Experiments were conducted
simultaneously in triplicate for all four cell lines. DNA concentration was used to control for
differences in cell number by dividing cell counts at each time point by the DNA concentration
an equal aliquot from time zero.
2.3.3 Flow challenge to assay cell adhesion and migration
Fibroblasts of each species were assayed for differences in cell adherence and migration
using a microfluidic device equipped with a time-capture, environment-controlled microscope
system, developed in Shelly Peyton’s laboratory (University of Massachusetts Amherst).
Fibroblasts at 80% confluency were trypsinized and 1,000-150,000 cells were seeded into the
flow cell device to monitor cell adhesion and migration over time (referred to further as
adhesion-in-flow experiments). The flow cell device uses two reciprocating syringe pumps
connected via tubing to a narrow chamber over which cells suspended in media were pumped
into at a rate of 50 µL/minute for 6 hours. Photographs of the fibroblasts adhering and migrating
in the flow cell were taken every 15 minutes over the 6-hour time course. Individual fibroblasts
were identified and assessed over the 6-hour observation period and were traced using FIJI
consecutively across this time period to obtain measurements of initial fibroblast adherent
surface area and subsequent cell spread via centroid X and Y coordinates over time [121]. These
data were used to plot migration paths of individual fibroblasts per species (SI Figure 1A).
Distance traveled of individual fibroblasts was calculated with a standard distance equation (D
= [(x2-x1)2 + (y2-y1)2]) [122]. Speed was calculated in microns/minute using total distance
traveled divided by time spent adherent for each individual cell [123]. Adherence duration was
calculated by averaging total lengths of time individual fibroblasts spent adherent. Timing of
fibroblast adherence was determined by comparing the proportion of fibroblasts adherent at a
particular time point (i.e. .5 hours, 1 hour) to that of the total number of fibroblasts that adhered
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over the entire time course. However, due to significant cell death, sufficient cell numbers (n =
25-30, per experiment) were obtained only for a single experiment per cell line (two individuals
per species) and we could not obtain the planned technical replicates per cell line we had
attempted. However, per species, we analyzed a minimum of 80 cells. Significant cell death
likely occurred due to the required changes from typical mammalian cell culture needed for this
assay, which included a transition from CO2-independent media to CO2-dependent media in
addition to consistent sheer force on these primary, un-immortalized cells due to the
reciprocating flow across the surface for the duration of the experiment.
2.3.4 Wound healing assay:
In order to assess interspecies differences in cell migration, we conducted a wound
healing assay as previously described [119, 120]. Briefly, 70-90% confluent fibroblasts were
dyed with a non-toxic cytoplasmic dye as previously described and scratched (“wounded”)
using a p200 pipette tip. Each well was then rinsed and media was replaced to remove cell
debris prior to taking fluorescent images (time 0). The same region of the well was subsequently
imaged at 24, 48, and 72 hours. We used CellProfiler (cellprofiler.org) to quantify the number
of cells that migrated into the wound and the area covered by cells over time [124]. Experiments
were conducted in triplicate for all four cell lines.
2.3.5 Identifying candidates for altered cell adhesion and migration from a study of
differential expression of genes during a wound healing response
In order to determine gene expression differences that may correspond to the
interspecies cellular differences in adhesion in our experiments, we used data produced by
Pizzollo et al. [105], a published study from our laboratory, that determined genes exhibiting
significant different expression (DE) (q-value < 0.05) between human and chimpanzee
fibroblasts undergoing a wound healing response. This study investigated global open
chromatin and transcription (via DNAse-Seq and RNA-Seq, respectively) in the same cell lines
investigated here. Pizzollo et al. [105] found genes exhibiting significant DE between species’
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fibroblasts at rest (unchallenged) and those undergoing a similar wound-healing response to the
one used in our experiments. For our analysis, we obtained these lists of significantly
differentially expressed (DE) genes from [105] and narrowed them down to those that are
members of the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways [64] for “focal
adhesion” and “cell adhesion molecules” (SI Table 2.1). We then compared whether they were
DE between species fibroblasts at rest, during the wound healing response, or both to determine
putative genetic differences underling the cellular phenotype differences in adhesion and
migration observed in our experiments.

2.4 Results
2.4.1 There are phenotypic differences in cell adhesion between human and chimpanzee
fibroblasts
In order to investigate if cellular phenotypes related to adhesion differ in manner
consistent with previously findings of significant differences in focal adhesions between human
and chimpanzee fibroblasts [104], we wanted to determine if there were differences in timing of
fibroblast adherence to a surface. In order to determine if there was a difference between species
in incidence of adhesion over time, we conducted multiple assays of fibroblast adhesion and
compared across species. Initially, we conducted a straightforward investigation of cell
adherence by seeding trypsonized fibroblasts into multiple wells and then removing excess,
suspended cells at sequential timepoints (.5, 1, 1.5, and 2 hours post-seeding) to count the
number of cells that had already adhered (Figure 4A). We expected that if chimpanzee cells
adhered more strongly than human cells, we would see more chimpanzee cells adhere during
earlier timepoints. We observed greater numbers of chimpanzee cells adhering than human
fibroblasts at all timepoints (Figure 4A). There was a statistically significant difference between
species (two-way ANOVA F=13.59, p = 0.0142) but not time (two-way ANOVA F=.62, p =
0.4665) (Figure 4A).
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We next used a more complex assay for cell adhesion using a flow cell device that
continuously flowed media with suspended fibroblasts back and forth over a plastic surface,
allowing us to monitor adhesion via photographs over a six hour time period (further referred to
as the ‘adhesion-in-flow’ assay). One benefit to this approach was that it allowed us to better
control cell number across experiments (100,000 per experiment for human cells, 150,000 for
chimpanzee cells). Individual fibroblasts were identified in these sets of images and traced over
time to obtain counts of adherent cells. We calculated percentages of observed adherent cells at
each time point as well as the length of time cells of each species remained adherent. When we
calculated the mean total length of time fibroblasts were adherent over the six hour time course,
chimpanzee fibroblasts were adherent for significantly longer (5.4 hours) than human
fibroblasts (4.56 hours, p < .001 ; Welch 2-sample T-test; Figure 4B) and adhered in greater
numbers within the first hour than human cells (Figure 4C). These results demonstrate
chimpanzee fibroblasts adhering faster than human fibroblasts and may mean chimpanzee cells
exhibit firmer cell adhesion than human fibroblasts.
2.4.2 Chimpanzee fibroblasts do not appear to inherently migrate faster or farther than
human fibroblasts but do exhibit faster in vitro wound healing
The increased number of focal adhesions in chimpanzee fibroblasts may also confer
differences in cell motility due to dynamic nature of disassembly and reassembly of focal
adhesion complexes during cell migration [107-110]. We investigated if there were inherent
differences in cell migration between species. Individual fibroblasts from the adhesion-in-flow
experiments were traced using FIJI software throughout the full six-hour experiment to obtain
area measurements and X & Y coordinates. In order to determine if there were differences in
migration patterns between fibroblasts, we used the centroid X and Y coordinates obtained from
the six-hour set of photographs to construct a plot of migration patterns between species (SI
Figure 6A). There appears to be little interspecies difference in migration patterns (SI Figure
6A), though, qualitatively, there does seem to be more movement along the Y-axis for human
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cells than chimpanzee cells. Using these coordinates, we calculated distance traveled and speed
of migration for each individual fibroblast over time. There was not a significant difference
between species in mean distance migrated (SI Figure 6B) or speed of migration (microns/hour,
SI Figure 6C). There was also no difference in cell spread (area/time, data not shown).
Given this fundamental biological link between focal adhesions and cell motility as well
as the evidence for greater adhesive properties of chimpanzee cells, we further assessed cell
migration by conducting wound healing experiments, which allow us to test a more biologically
relevant scenario of cell migration (SI Figure 6A). Wound healing assays, also known as
‘scratch tests’ are a straightforward way to investigate cell migration in vitro, and involve
making a scratch in a monolayer of cultured cells and monitoring the scratch over time as cells
respond to the gap [119, 120] (Figure 5A). We found a statistically significantly increase in
number of chimpanzee fibroblasts that migrated into the wound (two-way ANOVA F=30.36, p
= 1.66e-06; Figure 5B). There was also a statistically significant difference in cell count for
both species in original scratch over time (two-way ANOVA F=62.02, p = 5.23e-10; Figure
5B). This resulted in chimpanzee fibroblasts covering a greater percentage of the initial
wounded area than human fibroblasts during the first 24 hours post-wounding (Figure 5C).
However, while there was a statistically significant difference in area covered over time (twoway ANOVA F=14.20, p = 0.000475), there was not between species (two-way ANOVA
F=1.18, p = 0.283221). These results demonstrate that larger numbers of chimpanzee fibroblasts
migrate into an in vitro wound than human fibroblasts do.
2.4.3 Human and chimpanzee fibroblasts increase expression of distinct FA and CAM
genes normally and during wound healing
In order to see how gene expression diverges during the wound healing response
between species, we harnessed previously published data from our lab that compared gene
expression profiles via RNA-Seq of human and chimpanzee fibroblasts during a serum
challenge that mimics both wound healing and metastasis, using many of the same cell lines as
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those investigated here [105]. In this study, while human and chimpanzee fibroblasts both
exhibited gene expression profiles characteristic of wound healing throughout the serum
challenge, there were a number of genes that were significantly differentially expressed (DE)
between species in the control, unchallenged samples (pre-challenge) as well as during the
wound healing response (SI Table 2.1) [105]. In order to determine what interspecies
differential expression might explain differences in adhesive properties between normal primary
fibroblasts, and may be coinciding with our observed increase in cell migration during the
wound healing assay, we identified genes involved in the KEGG “focal adhesion” (FA) and
“cell adhesion molecules (CAMs)” pathways from the lists of genes Pizzollo et al. (2018)
identified as significantly differentially expressed (DE) between species’ in the normal,
unchallenged fibroblasts and during the serum response (12 and 24 hours post-serum
reintroduction) [105]. Cell adhesion and migration is modulated by interplay between cell
adhesion molecules and focal adhesions [125], and understanding the changes in their
expression during a wound healing response can provide insight into the genetic influences on
these cellular level phenotypes. There were 27 FA and 31 CAM genes DE between species at
any timepoint (SI Table 1). We focused on those that belonged to functionally distinct adhesion
related gene families in order to determine if there were interspecies differences expression in
these gene families in unchallenged or serum-challenged fibroblasts. Several cadherin genes
were DE between species at all timepoints, with CDH2 and CDH4 more highly expressed in
humans and CDH1 and CDH3 more highly expressed in chimpanzees (SI Table 2.1,2.2).
Chimpanzee fibroblasts exhibited significantly greater expression of the collagen gene COL4A6
at all time points and COL9A3 during the serum challenge while human fibroblasts only
significantly increased expression of the collagen genes COL6A1 and COL6A3 during the
serum challenge (SI Table 1,2). Chimpanzee fibroblasts had significantly higher expression of
integrins at all time points (ITGA7 and ITGA9, SI Table 2.1,2.2) while human fibroblasts did
not. Human fibroblasts increased LAMA4 expression during the serum challenge while
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chimpanzee fibroblasts always exhibited higher expression of LAMC3 and increased LAMA3
and LAMC2 when unchallenged (SI Table 2.1,2.2). Chimpanzees exhibited greater expression
of the syndecan gene SDC2 at all time points, but unchallenged human cells upregulated SDC3
and while unchallenged chimpanzee cells upregulated SDC4 (SI Table 2.1,2.2). Interestingly,
chimpanzees exhibited higher expression of a number of these genes at all timepoints,
regardless of challenge-state (Table 4). This highlights that humans and chimpanzees are
upregulating distinct genes from of FA/CAM protein families that may contribute to
interspecies differences in adhesion and migration cellular phenotypes.

2.5 Discussion
Our results demonstrate that chimpanzee fibroblasts adhere faster using multiple cell
adhesion assays (in static and in flow) (Figures 4 & 5). We consistently observed the most stark
interspecies differences at earlier time points: within the first hour for in static experiments
(Figure 4A), the first two hours (in terms of cell count) during the adhesion-in-flow experiments
(Figure 4C) likely contributing to the longer overall time adherent for chimpanzee cells (Figure
4B), as well as in the first 24 hours of the wound healing assay (Figure 5B, C). Significance in
interspecies difference in cell count dropped at later time points: post-3 hours for adhesion-inflow experiments (Figure 4C) or beyond 24 hours in the wound healing assay (Figure 5C) or
became unreliable to assess in in static adhesion assay (Figure 4A, decrease in cell number at
later times). These results in light of previous work demonstrating greater numbers of focal
adhesions in chimpanzee fibroblasts [104] may suggest that biological processes dependent on
rapid adherence of cells surface may differ significantly between human and chimpanzees, but
those relying on more gradual adherence or cell migration may ultimately end up with similar
phenotypes across species.
Given that stronger cell adhesion is associated slower cell migration [125], it is at first
potentially paradoxical that we appear to observe stronger adhesion in chimpanzee fibroblasts
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during the early timepoints of our adhesion experiments (Figure 4), no difference in overall cell
speed or distance between species fibroblasts (SI Figure 1) but apparently faster cell migration
of chimpanzee fibroblasts in our wound healing assay (Figure 5B). The biological context of
these different assays likely plays a role. Our adhesion-in-flow experiments were stressful for
these primary cells regardless of species, exemplified by high cell death (see Methods). These
also assess cell migration in different contexts, one with initial cell adherence followed by
migration in a challenging, flowing environment (adhesion-in-flow) while the wound healing
scratch test assesses migration of already adherent cells into newly unoccupied space. Given
that scratch/wound healing assays are a commonly used, classic assessment of cell migration,
we feel these results are robust.
It appears that human fibroblasts may be larger than chimpanzee fibroblasts during our
in vitro wound healing assay (Figure 5A). This may be responsible for the lack of significant
difference between species in area covered by species in a two-way ANOVA over all times
(Figure 5C). However, there is significant difference in percent of area covered at 24 hours
post-scratch (Figure 5C). Our in vitro assessment of wound healing is not sufficient to
ultimately determine if interspecies differences in cell size contribute more strongly to the
anecdotal evidence of faster wound healing than number of cells migrating into wound.
However, the previous work that determined that chimpanzee fibroblasts have greater numbers
of focal adhesions per cell than humans controlled for differences in cell size [104], and so this
does not ultimately negate these results. However, though it is not within the scope of the
current study, an interesting future direction could be if the there is a larger trend toward larger
cells in humans and if so, if there is any corresponding biological advantage in processes such
as wound healing or cell motility.
Harnessing RNA-Seq data of the same cells lines during a similar wound-healing and
cancer-like in vitro assay [105] allowed us to examine gene expression changes coinciding with
interspecies differences in adhesion and migration during a wound healing response. We were
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unable to use these data to compare gene expression differences in vinculin to corroborate the
finding by Advani et al. [104] of interspecies differences in vinculin staining because it was not
one of the genes included in Pizzollo et al. [105]. However, it seems that interspecies
differences in adhesion and migration may largely be driven by the constitutively higher
expression of other CAM and FA genes in chimpanzee fibroblasts, at rest and during a wound
healing response (Table 4). Cell adhesion and migration is modulated by interplay between cell
adhesion molecules and focal adhesions [125] and concerted increases in expression of both
likely is responsible for important interspecies differences in adhesion and cell motility.
Integrins are a family of heterodimeric proteins transmembrane proteins with a critical roles in
focal adhesion complexes as bidirectional signaling between the interior of the cell and the
ECM, and vice versa [107, 108, 126]. It is interesting that chimpanzee fibroblasts but not human
fibroblasts exhibited greater expression of integrin proteins regardless of serum status (Table 4,
SI Table 2) [105]. Given that integrins are directly involved in communicating signals
bidirectionally across the plasma membrane, this may indicate that chimpanzee fibroblasts have
enhanced FA signaling compared to human fibroblasts, which may contribute to the phenotypes
observed here of enhanced adhesive and motile properties in chimpanzee fibroblasts.
One of several of the major disparities in disease occurrence between humans and
chimpanzees is that of incidence and progression of metastatic cancer. Though we clearly lack
the same extensive population-level understanding of cancer incidence in chimpanzees, the data
we do have from necropsies of captive chimpanzees indicates that epithelial cancer occurs at a
rate of < 4%, in sharp contrast to the > 20% of human deaths due to epithelial neoplasms, such
as breast or lung carcinomas [100, 127-130]. Of further biomedical relevance, there is
anecdotal evidence that humans and chimpanzees also differ in wound healing [131].
Intriguingly, these two disease states are linked – tumors have been described as wounds that do
not heal [102] and gene expression profiles of cancerous tissue mimic that of tissue undergoing
wound healing [132, 133]. The interspecies disparities in wound healing and cancer incidence
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may be due to alterations in the basic biological processes common to both of them, namely,
cell adhesion and migration. Cancer is complex disease that results from aberrations of some of
the most fundamental biological processes, including cell growth, proliferation, and migration.
Fundamental differences in these processes between humans and chimpanzees may help explain
to some extent the significant differences in cancer-related deaths. Several integrins expressed
in epithelial cells influence metastasis, though whether increased or decreased expression in
cancerous compared to normal tissue is inconsistent across integrins and cancer types [134].
Both of the integrins with increased expression in chimpanzee fibroblasts have been linked to
metastasis in cancerous cell lines [135-138]. Reduced expression of ITGA7 was implicated with
greater cell motility and metastasis [139] and thus there is potential that increased integrin
expression in chimpanzee fibroblasts does contribute to decreased cell motility and potentially,
decreased metastasis of cancerous cells. All of the cadherins up regulated in human (CDH2,
CDH4) and chimpanzee (CDH1, CDH3) are implicated in cancers of various kinds (Roy 2014).
CDH1 and CDH3 expression typically overlap (Roy 2014).
Furthermore, extracellular matrix proteins important for cell adhesion and migration
include laminins and collagens. Collagen IV is the main collagen composing the basement
membrane. COL4A6 was upregulated in chimpanzees at all timepoints (SI Table 2.2). However,
during the serum challenge, humans upregulated COL6A1, COL6A3, and LAMA4 while
chimpanzees upregulated COL9A3 in addition to their always upregulated COL4A6. This
suggests that during a wound healing response, both species will upregulate secretion of
basement membrane proteins of the ECM of similar families, but not the same genes. Finally,
syndecans are transmembrane glycoproteins whose extracellular domains often act as coreceptors [140]. Interestingly, in normal fibroblasts, humans upregulated syndecan-3 (SDC3), a
syndecan primarily found in adults in neuronal tissues (Table 4, SI Table 2.2) [140].
Chimpanzees upregulated SDC2 at all timepoints and SDC4 in normal fibroblasts, both of
which are broadly expressed syndecans across multiple tissue and cell types [140]. This is in
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line with previous findings that altered gene expression in humans is enriched for neural
processes [140]. This may represent a shared evolutionary pressure for increased neural activity.

2.6 Conclusions and Implications
The degree of change in coding sequence and protein function between humans and
chimpanzees has long known to be insufficient to explain the stark phenotypic differences
between these species [37, 99, 100]. Alterations in gene expression are known to influence
human-specific phenotypes, including some that influence disease [97-99, 141]. However, this
is one of few studies demonstrating that these divergences in expression can manifest in
fundamental differences in cell biology. We demonstrate that there are functionally important
differences at the cellular level between species corresponding that correspond with significant
interspecies divergence in gene expression in wild-type unchallenged fibroblasts as well as
those undergoing an in vitro mimic of both wound healing and cancer. Our study represents one
of relatively few investigations into the basic cellular differences between species that may
allow us to better understand evolutionary of complex disease traits
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Figure 4 | Adhesion differences between human and chimpanzee fibroblasts. Fibroblasts from
two individuals per species were assayed for adherence in static (A) and in flow (B, C). A)
Adhesion-in-static assay. Mean count per timepoint normalized for differences in cell number
by dividing raw cell counts at each time point by the DNA concentration from time zero. B)
Comparison of the duration of fibroblast adherence in flow (per species) (p < .001 ; Welch 2sample T-test). C) Comparison between species of the timing of fibroblast adherence over the
6-hour time course.
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Figure 5 | Interspecies differences in wound healing. A) Representative images of human and
chimpanzee fibroblasts undergoing a wound healing response after initial scratch (0), and 24,
48, and 72 hours post-scratch. CellProfiler was used to quantify the number of cells that moved
in to fill in the scratch (B) and the change in area covered by cells (C) at 0, 24, 48, and 72 hours
post-scratch.
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Table 4
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Table 4 | FA and CAM genes DE between species during a serum challenge. Comparison of
DE patterns of major adhesion gene family genes during serum challenge or at all time points.
Asterisks indicate membership in KEGG pathway: * Cell Adhesion Molecules (CAM), **
Focal Adhesion (FA), *** both.
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2.8 Supplemental Figures
SI Figure 6
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SI Figure 6 | Human and chimpanzee fibroblast migration. Migration patterns of all observed
human and chimpanzee fibroblasts plotted using X & Y coordinates obtained from FIJI (A).
Species means for total distance traveled (B) and speed (C) of individual fibroblasts.
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CHAPTER 3

INVESTIGATING CELL-TYPE SPECIFIC SHIFTS IN METABOLIC GENE
EXPRESSION BETWEEN HUMANS AND CHIMPANZEES

3.1 Abstract3
The human brain is more energetically costly than that of other primates, utilizing ~
20% of all of the body’s metabolic resources, while chimpanzee brains use less than 10%.
Previous work on whole brain tissue has consistently determined significant differences in
metabolism between species; yet, a cell-type specific comparison is necessary to understand
distinct cellular contributions to interspecific differences in neurological function. Here, we
conducted a cell-type specific investigation of neural differences between humans and
chimpanzee by conducting RNA-Seq on neural progenitor cells (NPCs), neurons, and astrocytes
generated from induced pluripotent stem cells (iPSCs) from both species. Differential
expression (DE) analyses demonstrate that the greatest proportion of genes exhibiting DE are
between species’ astrocytes (12.2% of all expressed genes), followed by NPCs (8.57%), and
neurons (5.8%). Categorial enrichment analyses of genes exhibiting DE show that all three
neural cell types display interspecies gene expression enriched for metabolic processes, driven
primarily by higher expression of metabolic genes in human cells. Gene set enrichment analyses
reveal that human neurons and astrocytes are enriched for greater glucose transport while
chimpanzee neurons and astrocytes exhibit greater lactate transmembrane transport. We also
determined cell-type by species differences in gene expression for nuclear- and
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mitochondrially-encoded subunits of the protein complexes important for oxidative
phosphorylation. This work circumvents the technical and ethical hurdles of investigating rare
cell types in primates to provide exciting insight into the cell type specific metabolic changes
that were necessary to support evolution of the human brain.
3.2 Introduction
Though primates exhibit widespread variation in many phenotypes, including anatomy,
behavior, and cognition, the extent of these phenotypic differences is not substantially larger
than differences in genome sequence [97, 98]. One of those traits that defines primates is a
significantly larger brain relative to body size, for which humans exhibit the greatest amount of
difference. In 1975, decades prior to sequencing the entire human genome, King and Wilson
hypothesized that phenotypic differences amongst humans and chimpanzees must largely be
due to changes in gene expression, as coding sequence differences were not nearly divergent
enough to account for those differences [37]. Subsequent investigations into differential gene
expression across species, and primates in particular, have reinforced the hypothesis that noncoding, cis-regulatory changes are critical for these large differences in phenotype [40-42].
Recent work has determined that changes in gene expression in the brain have been found to be
both functionally and evolutionarily important [40, 41, 44, 51, 83, 142]. Changes in non-coding
regions of the genome identified to be under positive selection in humans are enriched for
biological processes and molecular functions that are neural-specific (e.g. synaptic signaling)
and those related to metabolism (e.g. carbohydrate and lipid metabolism) in various studies of
human, chimpanzee, and rhesus macaque brains [39-41].
Within primates, selective differences in the genome can be linked to diet and
metabolism, suggesting selection has optimized different metabolic processes in lineagedependent ways [39-41, 80-83]. The human brain is more energetically costly than that of other
primates, utilizing ~ 20% of all of the body’s metabolic resources, in comparison to non-human
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primate brains that use less than 10% [84, 85]. Importantly, allometry alone does not explain the
increase in human brain appropriation of glucose metabolism at this proportion [86-88]. There
is evidence that sheer increase in neuron number can explain at least part of the energetic
demand of the human brain [143]. However, interspecies differences in the contribution of
metabolism of astrocytes versus neurons to metabolic capacity at the organ level remain largely
un-explored.
Many of these changes in brain metabolism have been hypothesized to coincide with
other trait changes, particularly those related to shifts in diet known to be important in hominin
evolution, such as an increase in meat products, increased quality of food, and agriculture [83,
144-149]. A recent study investigating an extensive number of primates is consistent with the
idea that diet is a better predictor of brain size than social group structure [63]. The expensivetissue hypothesis posits that a trade-off in energy allocation for the development of a larger,
metabolically demanding brain in primates coincided with a reduction in gut tissue [144, 150152]. Similarly, an increase in energy-storing tissue (adipose tissue) at the expense of
energetically demanding muscle tissue may have also allowed for greater allocation to a larger
brain [153-155]. There is evidence that the higher metabolic costs of the human brain influences
the protracted development of body growth rate [142]. Evolutionary differences in brain
metabolism are a subset of studied differences in metabolic traits that exhibit intriguing
differences across primate species. Primates exhibit a lower total energy expenditure (TEE) to
body size ratio than non-primates, and furthermore, humans have greater TEE than closely
related great ape species (chimpanzees, bonobos, gorillas, and orangutans) due in large part to
increased basal metabolic rate (BMR), all of which is consistent with the reallocation of
metabolic investment to brain [151, 156]. These in vivo (whole organism) studies further
suggest an important link between evolutionary differences in metabolism and the uniqueness of
the primate brain.
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Similar to organism-level investigations, there is also molecular evidence supporting
the evolution of metabolic processes (e.g. oxidative phosphorylation) in the primate brain with
phylogenetic proximity to humans. Metabolism in the brain is critical for neurological function,
as it provides cellular energy and critical biomolecules necessary for the complex cellular
network characteristic of the brain [69-71, 157-160]. Cellular metabolism involves the
breakdown of fuel molecules to produce energy or other molecules through multiple
interconnected pathways, including glycolysis, oxidative phosphorylation, and the pentose
phosphate pathway. Enrichments for metabolic processes in genes and gene regulatory regions
undergoing positive selection is a common thread in gene expression analyses from whole
primate brain tissue [39-42, 161, 162]. However, there are lineage-dependent differences in the
specific pathways enriched between species (e.g. glucose and carbohydrate metabolism in
humans and glycogen and acyl-CoA metabolism in chimpanzees) [42, 161, 162], as well
regions of accelerated genomic change in a lineage-dependent manner [163, 164]. Within
anthropoids, genes encoding the subunits of cytochrome c oxidase, the final component of the
electron transport chain, show an accelerated rate of evolution in their sequences compared with
any other placental mammals [165]. These changes at the gene level are indicative of increased
control over the mechanisms that process glucose [162, 166-169]. Further understanding genephenotype relationships between genetic changes (both in coding and non-coding regulatory
portions of the genome) and observed metabolic differences in primates will contribute to a
greater understanding of proximate influences on larger evolutionary trends in primates. These
findings also highlight a need to investigate not only glucose metabolism and energy production
but also that of other macromolecules (e.g. lipids, amino acids, nucleic acids) for a more
comprehensive understanding of differences in cellular metabolism in neural cells of primates.
The findings of interspecies divergence in brain metabolism are intriguing, however, a
cell-type specific comparison would more fully inform our understanding of distinct cellular
contributions to interspecific differences in neurological function [170]. Two of the major cell
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types in the brain are neurons and astrocytes. Neurons are responsible for neurological functions
like cognition and perception largely by transmitting chemical and electrical signals throughout
complex cellular networks. However, non-dividing, mature neurons are known to have very
little capacity for specific metabolic processes (e.g. glycolysis) and rely on metabolite shuttling
from another cell type, astrocytes [171-173]. Astrocytes, despite being the most abundant celltype in the central nervous system [174], have traditionally been considered support cells for
neurons, without significant relevance to neural function. However, recent work has determined
critical roles of astrocytes in neural function including provisioning of metabolites to neurons
for energy [73, 175, 176] and enhancing synaptic processes [177, 178]. These findings point to
a need to characterize the important differences among a variety of cell types, not only in
neurons, but in other metabolically-relevant brain cell types such as astrocytes between species
to understand how the primate brain has evolved metabolically.
We hypothesize that there are important cell-type specific metabolic changes between
human and chimpanzee brains and that astrocytes contribute, at least in part, to these
differences. To investigate these changes, we used established protocols for the differentiation
of induced pluripotent stem cells (iPSCs) into mature, functional neurons and astrocytes from
humans and chimpanzees from multipotent neural progenitor cells (NPCs). This novel
comparative approach allowed us to functionally test each cell type in the absence of other cell
types in a defined, controlled environment. In order to determine adaptive interspecies
differences in gene expression and metabolism in cell-type specific manner, we conducted
RNA-Seq on human and chimpanzee NPCs, neurons, and astrocytes.

3.3 Materials and Methods
3.3.1 Samples and Cell Culture
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Induced pluripotent stem cells (iPSCs) from three individuals (cell lines) per species
(human and chimpanzee) were cultured in defined, iPSC-specific media mTeSR1 (STEMCELL,
Vancouver, Canada). These cell lines were originally obtained as fibroblasts from minimally
invasive skin biopsies, reprogrammed into iPSCs, and have been extensively validated for their
pluripotency and differentiation abilities [170, 179-184]. Three cell lines per species,
representing three male individuals, were used (SI Table 3.1). To investigate differences
between human and chimpanzee neural cell types, we induced iPSCs from each species first
into multipotent, neural-lineage committed neural progenitor cells (NPCs) using STEMdiff
Neural Induction Medium in monolayer for three passages (21-28 days), as per manufacturer’s
instructions (STEMCELL Technologies, Vancouver, Canada). Successful transition of iPSCs
into NPCs was determined using immunofluorescence for the absence of the stem-cell marker
OCT4 and presence of the NPC-marker PAX6 (Figure 7A). NPCs were then expanded into
three subsets: one for RNA collection, and two for further differentiation and maturation into
neurons and astrocytes. We then differentiated NPCs into mature neurons and astrocytes using
the neuron and astrocyte specific STEMdiff differentiation and maturation kits as recommend
by the manufacturer. Briefly, we differentiated NPCs using the STEMdiff Neuron
Differentiation Medium for one week and then matured them using the STEMdiff Neuron
Maturation Medium for two weeks. Similarly, we differentiated NPCs using the STEMdiff
Astrocyte Differentiation Medium for three weeks and then matured them using the STEMdiff
Astrocyte Maturation Medium for two weeks. All cells were validated for cell type via
immunofluorescence prior to harvesting as follows: NPCs for PAX6+/OCT4- (Developmental
Studies Hybridoma Bank, University of Iowa), neurons for neuron-specific class III b-tubulin
(TUJ1; Neuromics), and astrocytes for GFAP (Sigma Aldrich), according to manufacturer’s
suggestions (SI Figure 13). All mature iPSC-derived cells for each cell type were harvested at
similar timepoints: NPCs at passage 5-6 post-induction from iPSCs, mature neurons at passage
3-4 and mature astrocytes at passage 5-6 post-differentiation from NPCs and subsequent
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maturation (SI Table 3.1). We used edgeR [58] to normalize our raw counts across all samples
and visualized these data using a multidimensional scaling (MDS) plot of all of the expressed
genes (Figure 7B).
3.3.2 Library Preparation and Sequencing
Total RNA was extracted from cells (1-2 wells, 6 well plate) using an RNeasy Plus
Mini Kit (Qiagen), including a DNase step to remove residual DNA. Total RNA was analyzed
for quality using the Agilent Bioanalyzer system (Agilent RNA 6000 Nano kit) with RNA
Integrity Numbers (RINs) for all samples between 8.3-10 (SI Table 3.1). Using the NEBNext
Poly(A) Magnetic mRNA Isolation Kit (NEB), mRNA was isolated from intact total RNA, and
cDNA libraries were made from each sample using the NEBNext RNA Ultra II Library Prep
Kit for Illumina (New England Biolabs). Barcoded samples were sequenced using the Illumina
NextSeq 500 platform at the Genomics Resource Core Facility (Institute for Applied Life
Sciences, UMass Amherst) to produce 75 base pair single-end reads, yielding a minimum of 32
million reads per sample.
3.3.3 Read Mapping and Quantification
Quality-filtered reads were aligned to respective species’ most recent ENSEMBL
genome (Homo sapiens GRCh38 and Pan troglodytes PanTro3.0 [53, 54]) with Bowtie2 [52]
using default ‘--local’ parameters for gapped alignments, with a minimum alignment percentage
of > 98.84% (SI Table 1). HT-Seq [55] was used to quantify counts per gene for each sample,
using ENSEMBL gene transfer files (GTFs) corresponding to the same genome build used for
alignment [56]. High quality, one-to-one orthologs from P. troglodytes were matched to the
ENSEMBL human reference set of genes using biomaRt [57], yielding 15,284 genes identified
as expressed in at least one sample.
3.3.4 Clustering Analyses
We used clustering analyses to determine the variation among our iPSC-derived
samples as well as in comparison to previously published, publicly available data from other
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tissues and cell types. For our iPSC-derived samples, we used the R package edgeR [58] to filter
out lowly-expressed genes (counts per million (CPM) > 1 in 12/17 samples), resulting in 10,715
orthologous genes, and produced an MDS plot of our samples (Figure 7B). The greatest
influence on our samples is species along PC1 and PC2, followed by separation of immature
NPCs cells from mature cell types (neurons and astrocytes) along PC2 (Figure 7B). Notably,
human samples were more variable than chimpanzee samples. One human cell line (H20961)
showed significant variation across all cell types (SI Figures 14-16), however, the H20961 NPC
sample was consistently an outlier, grouping outside of NPCs of either species, and was
removed from subsequent analyses. There are no overt technical differences influencing this
out-grouping (e.g. individual sex or age, RNA or cDNA library quality, read number, alignment
percentages, SI Table 3.1). This cell line has successfully been used in before in other
differentiation studies with no overtly different characteristics [170, 179-184].
To compare our samples to previously published data from cells and tissues, we
downloaded raw RNA-Seq reads from the NCBI’s Gene Expression Omnibus (GEO) [185] and
processed them from raw read counts through HT-Seq and orthologous gene matching in the
same manner as our iPSC-derived samples. To compare our samples to those from primary
neural cell types, we used RNA-Seq data from primary neurons and astrocytes obtained from
four hippocampal astrocytes, four cortex astrocytes, and one cortical neuron from [186] (GEO
accession number GSE73721) and three pyramidal neuron samples (GEO accession numbers
GSM2071331, GSM2071332, and GSM2071418) isolated from an unspecified brain region by
the ENCODE project [187, 188]. We also downloaded the tissue-level data from Brawand et
al., (2011) [45] from human and chimpanzee brain regions and non-neuronal tissue (heart,
kidney, liver) (GEO accession number GSE30352) (SI Table 3.2 for details). Only genes with
counts greater than zero in all samples were included and were further filtered to include only
those with CPM > 1 in all 23 samples. An MDS plot of normalized counts was generated using
edgeR of the top 500 most differentially expressed genes in all samples (SI Figure 17).
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3.3.5 Differential Gene Expression Analyses
In order to determine what genes were significantly differentially expressed in a species
by cell type manner using, we used the R package edgeR’s [58] generalize linear model (GLM)
functionality with a design matrix accounting for an interaction between species (SP) and cell
type (CT) (referred to as SPxCT DE analysis). We performed an analysis of variance
(ANOVA)-like test for differences across all samples. Furthermore, in order to determine what
differences existed between species for each cell type, we performed interspecies pairwise DE
comparisons in a similar manner between NPCs, neurons, and astrocytes (referred to as CT-DE
analyses). We also used the GLM for these analyses, but did not include more than one cell type
in these analyses in order to include genes that may be cell-type specific. For all analyses, we
used edgeR’s quasi-likelihood F-test and considered gene expression significantly different at a
false discovery rate (FDR) of less than 5%. Normalization of data in edgeR for DE analyses
ensured that DE is not dependent on original number of cells. All Venn diagrams were created
using the R package Vennerable.
3.3.6 Categorical Enrichment Analyses
Uninformed pathway enrichment analyses were conducted using genes identified as
differentially expressed from each DE comparison using gProfiler [189] with their functional
enrichment tool (g:GOSt). Categorical enrichment analyses for overrepresented (enriched) and
underrepresented (conserved) processes were conducted on all genes identified as differentially
expressed (FDR < .05%) between species for individual cell types. Enrichments with a q-value
of < .05 were considered significant.
3.3.7 Gene Set Enrichment Analyses
In order to investigate which metabolic pathways were enriched in a species’ CT, we
used Gene Set Enrichment Analyses (GSEA) [190]. We tested for enrichment of 23 a priori
gene sets from the Molecular Signatures Database (MSigDB) [191] using the raw counts of the
same set of genes used for the CT-DE pairwise comparisons. Gene sets were considered
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significantly enriched according to suggested thresholds (FDR < 25% and nominal p-value <
.05) [190]. Leading edge analyses determined a set of core enriched genes that most
significantly influenced the enrichment of the gene set per phenotype.
3.3.8 Selection Analyses
In order to determine if genes exhibiting significant interspecies differential expression
also had evidence of positive selection in their coding sequences, we used nonsynonymous (dN)
and synonymous (dS) nucleotide changes per gene for all genes expressed in iPSC-derived
neural cells. These were obtained from Ensembl using biomaRt (Kinsella et al., 2011). These
pre-calculated dN and dS values were originally computed by Ensembl using codeml and yn00
of the PAML package to compute dN and dS scores for each species in comparison to human
(Herrero et al., 2016). A rate of change was calculated for each gene (dN/dS), where a dN/dS >
1 is indicative of positive selection [192].
3.3.9 Network Schematic
We constructed a focal set of signaling pathways based upon HumanCyc [193] in order
to contextualize our DE results in the framework of a network signaling, and this is the diagram
of the major pathways involved in aerobic glycolysis (glycolysis, pentose phosphate pathway
(PPP), lactate conversion from pyruvate, and TCA cycle) shown in Figure 12. For each enzyme
in the pathway, three blocks indicate expression of this enzyme in each cell type – left to right:
NPCs, neurons, astrocytes. Color indicates level of expression (higher in human (red), higher in
chimpanzee (blue), not expressed in this cell type (grey)).

3.4 Results
3.4.1 RNA-Seq of human and chimpanzee iPSC-derived neural cells
We took a comparative genomics approach to investigating interspecies differences in
neural cell-type specific gene expression between humans and chimpanzees. Three cell lines per
species, representing three individuals, were used. These cell lines were originally obtained as
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fibroblasts from minimally invasive skin biopsies, reprogrammed into iPSCs, and have been
validated for their pluripotency and differentiation abilities [170, 179-184]. iPSCs from both
species were initially cultured in the defined, iPSC-specific media mTeSR1 (STEMCELL,
Vancouver, Canada). In order to investigate interspecies differences in cell-type specific gene
expression between humans and chimpanzees, we generated RNA-Seq data from human and
chimpanzee neural progenitor cells (NPCs), neurons, and astrocytes from induced pluripotent
stem cells (iPSCs).
To confirm that expression profiles of our iPSC-derived neural samples resembled that
of neural tissue and primary neural cells, we used previously published data from human and
chimpanzee tissues, including brain [45], as well as human primary neurons and astrocytes
(Methods) [186]. We visualized these data in an MDS plot and observed that our iPSC-derived
neural samples clustered together within the same dimensional space as the other neural tissue
and cell samples and not nearer to the non-neuronal tissue samples (SI Figure 17). These
clustering analyses demonstrate that we successfully created and obtained total transcriptome
data of iPSC-derived NPCs, neurons, and astrocytes from humans and chimpanzees relevant for
comparative assessments of cell-type specific interspecies gene expression differences.
3.4.2 Differential expression between human and chimpanzee neural cell types
We next performed differential expression (DE) analyses in order to determine
significantly differentially expressed genes between species. However, given the lack of clear
distinction among our different cell types (Figure 7B), we first wanted to determine the degree
of shared expression across all cell types to inform our investigation of cell-type specific
differential expression. To do so, we determined overlap among cell types for genes with at
least one count in one or more cell lines per cell type (Figure 7C). Of the total genes expressed
in NPC (n=14,877), neuron (n=14,961), and astrocyte (n=14,931) samples, 95.13% (n=14,536)
were shared among all three cell types (Figure 7C). This demonstrates that very few genes are
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cell-type specific in the brain, similarly to other studies of gene expression across brain regions
and cell types [72, 194].
For DE analyses, we first conducted an analysis of variance (ANOVA)-like test for
differentially expressed genes in a species (SP) by cell-type (CT) manner using edgeR [58]. We
reasoned that this would be the most evolutionarily relevant set of genes for investigating neural
cell-type specific “trade-offs” in expression between species. Using edgeR’s generalized linear
model (GLM) functionality and a quasi-likelihood F-test for significant differential expression,
we found 4,007 significantly differentially expressed genes in a species by cell type manner
(26.22% of all expressed genes). However, at present, there are no post-hoc tests for an
ANOVA-like test for differential expression, and so this analysis is limited in that it cannot
delineate which samples (cell types) these genes are significantly DE in [58]. The ANOVA-like
test for differences also requires an initial filtering of lowly expressed genes across all samples,
which eliminates the 104-120 genes (0.68-0.79%, Figure 7C) expressed only in one cell type
(CT-specific genes). For these reasons we also conducted interspecies pairwise DE comparisons
for each CT (hereafter referred to as CT-DE analyses). While these CT-specific genes are
relatively few in number, they likely have an important role in cellular function, and thus we did
not want to exclude them from our interspecies CT-DE comparisons.
For CT-DE comparisons, the only genes included were those counts above zero in all
samples per CT and were further filtered to those with counts per million (CPM) > 1 in at least
1 sample, resulting in 11,772 genes in NPCs, 12,451 genes in neurons, and 12,302 genes
expressed in astrocytes. We used the same GLM quasi-likelihood F-test to determine that 8.57%
(n=1,294) of genes are differentially expressed between species’ NPCs, 5.8% (n=886) between
neurons, and 12.2% (n=1,865) between astrocytes (Figure 8A, SI Figure 18). Many of these
significantly differentially expressed genes in CT-DE comparisons overlapped with the SPxCT
ANOVA-like differentially expressed genes (SI Table 3.3). When we determined overlap in
differentially expressed genes between species across all three cell types, we found that, similar
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to global expression, a large number of genes were determined as differentially expressed
between species in all three cell types (n=594, Figure 8B). However, there are far more genes
that uniquely differentiate astrocyte gene expression between species (n=924) than NPCs
(n=395) and neurons (n=100) (Figure 8B). This suggests that neuronal gene expression is more
conserved across species in NPCs and neurons, and that astrocytes do indeed contribute to
important interspecies differences in neural gene expression.
3.4.3 Interspecies differences in gene expression are largely due to differential metabolic
signaling skewed toward higher expression in humans, regardless of cell type
We then used categorical enrichment analyses to determine what biological processes
are over-represented (enriched) or under-represented (“conserved”) in interspecies differentially
expressed genes by cell type (CT) (SI Table 3.4). There were consistently a larger number of
interspecies differentially expressed genes per CT-DE comparison with higher expression in
human cells (765 in NPCs, 496 in neurons, and 1,078 in astrocytes) than chimpanzee cells (529
in NPCs, 390 in neurons, and 787 in astrocytes) (Figure 8A). We used these six higher-in-onespecies split DE gene lists in a mutliquery categorical enrichment analyses for under- and overrepresented processes using gProfiler’s categorical enrichment tool (gOST) [189]. Likely in part
due to the larger number of genes with higher expression in human for all CT’s, there was
consistently far more processes enriched in human CTs than chimpanzee CTs (SI Table 3.4).
Human and chimpanzee neural cells exhibited significant under-representation of the
KEGG pathways ‘olfactory transduction’ and ‘neuroactive ligand-receptor interaction’ (Figure
8C). Consistently, both species’ also showed significant under-representation of GO BP related
to development, immune function, and intracellular signaling (SI Figure 20). Human cells
exhibited under-represented for some extracellular and membrane associated cellular
components (CC) (SI Figure 21) as well as molecular function related to cytokine and receptor
activity (primarily in astrocytes; SI Figure 22). Both species cells were underrepresented for
nucleic acid binding and G-protein coupled receptor and transducer activity (SI Figure 22). This
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demonstrates that signaling, including some neuronal-specific signaling such as neuroactive
ligand receptor interaction, and downstream perception processes (e.g. olfaction) are conserved
across species for all cell-types.
As for significantly over-represented processes in differentially expressed genes
between species, cell division, cytoskeletal, developmental, signaling and response to external
stimuli terms were significantly over-represented in human astrocytes, transcription was
enriched in human NPCs, and protein modification was enriched most significantly in human
neurons (SI Figure 20). Metabolic processes targeting a variety of substrates or macromolecules
were enriched in human cells (summarized in Figure 8D, full results in SI Table 3.4). Human
neurons and astrocytes were enriched for protein metabolic processes, while human NPCs were
not. Conversely, human NPCs and astrocytes were enriched for metabolism of nitrogen
containing and aromatic compounds while human neurons were not. Human astrocytes were
significantly enriched for several more metabolic biological processes than human NPCs and
neurons that included metabolism of phosphate-containing compounds as well as more
generally for metabolism of macromolecules (Figure 8D). These results indicate that though
interspecies divergence in metabolic gene expression does occur in all three cell types, it does
not always do so for the same metabolic pathways in all cell types.
We also investigated enrichment of GO cellular component (CC) terms to determine if
there were differences in expression of specific neuronal parts. Over-represented CC terms in
human astrocytes were similar to the GO BP over-represented processes (cytoplasm,
cytoskeleton; (SI Figure 21A) as well as cell-parts involved in cellular division and growth (SI
Figure 21B). Human neurons were enriched for terms related to the Golgi apparatus and
macromolecule complexes (SI Figure 21A) and those specific to protein modification and
signaling (SI Figure 21B). Human astrocytes were enriched for molecular functions (MFs)
related generally to substrate binding, and specifically, to ATP, carbohydrates & their
derivatives, enzymes, and nucleic acids (SI Figure 22A). The only over-represented GO MF
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binding activity for chimpanzee cells was for that of oxidoreductase activity in chimpanzee
NPCs (SI Figure 22B). Human NPCs were enriched for TF activity, human neurons for
ubiquitin-related molecular activity, and human astrocytes for molecular activity related
generally to ATPases, catalysis, exonucleases, helicases, kinases, and phosphotransferases (SI
Figure 22B). These results indicate that metabolic processes differ between species in a CTspecific manner, and that all human neural cell types exhibit increased expression for a variety
of macromolecular metabolic processes more than chimpanzee neural cells. Further, we see that
there are significant differences in molecular functions important in cellular metabolic
signaling.
3.4.4 Human and chimpanzee neural cells differ in glucose and lactate transport as well as
oxidative phosphorylation
Metabolic processes targeting a variety of substrates or macromolecules were enriched
in human neural cell types using uninformed categorical enrichment analyses. However, very
few of these processes were for pathways involved in cellular respiration resulting in production
of energy (in the form of ATP). We were interested if there were significant interspecies
differences in gene expression for pathways involved in cellular respiration, specifically, those
involved in aerobic glycolysis. Because there are known differences in metabolic capacity
between neurons and astrocytes, including that astrocytes are characterized metabolically by
high aerobic glycolytic activity (increased glycolysis and limited potential for oxidative ATP
production) while neurons typically favor energy production and oxidative phosphorylation
[reviewed in 72], we were interested in determining any interspecies, cell-type specific
differences in these brain metabolic processes. To further investigate this, we used a Gene Set
Enrichment Analysis (GSEA) [190] with 23 a priori gene sets on the raw counts of the 12,407
genes used for interspecies pairwise CT-DE analyses. Gene sets were obtained from the
Molecular Signatures Database (MSigDB) [191] and chosen in order to probe a variety of
energetic metabolic pathways and substrate transporters of varying gene number size from
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multiple ontology categories (GO, KEGG, and REACTOME) (all probed gene sets listed in
Figure 9A) [64-66, 195]. The goal was to determine if pathways involved in aerobic glycolysis
(e.g. oxidative phosphorylation, glucose transport, TCA cycle) differ in a species by cell type
manner, and so pathways not directly involved in aerobic glycolysis (e.g. fatty acid metabolism)
are included as a comparison. We also included “control” pathways not directly related to
metabolism (regulation of growth, and neurotrophin signaling).
Our GSEA results indicate that the gene sets for lactate transmembrane transport,
glucose transport, oxidative phosphorylation, and metabolism of RNA are significantly different
between human and chimpanzee neural cells (FDR < 25% and nominal p-value < .05; Figure
9A, B, SI Table 3.5). Glucose transport was enriched in human neurons and astrocytes while
lactate transmembrane transport was enriched in chimpanzee neurons and astrocytes (Figure
9A, B). The GO gene set for oxidative phosphorylation is significantly enriched in all human
cell types while the KEGG oxidative phosphorylation is upregulated in chimpanzee astrocytes
(Figure 9A, B). These results indicate cell-type by species differences in glucose uptake by
cells, lactate shuttling, and diverging energetic cellular respiration.
3.4.5 There are species by cell-type differences in expression of oxidative phosphorylation
protein complexes
Leading edge analyses of significant GSEA gene sets are used to determine which
genes of the gene set contribute most strongly to the enrichment of that pathway in the
phenotype [190]. We examined the results from the leading edge GSEA analysis with CT-DE
expression analyses to get a better idea of how these three pathways diverge in a cell type by
species manner (Figures 10 and 11; full results in SI Table 3.6). We calculated a rank for DE
genes for each CT-DE comparison (NPC, neuron, and astrocyte): (sign of logFC) x log10(FDR
Q-value) [196] and used that in addition to the GSEA leading edge analysis to determine
significant differences. For the oxidative phosphorylation genes, we were interested in
determining why there was a difference in species and cell type enrichment based on the source
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of the gene set (KEGG vs GO) and determining if there were potential functional differences in
oxidative phosphorylation between species. We mapped the CT-DE rank of the core enriched
genes for GO (Figure 10A) and KEGG (Figure 10B) oxidative phosphorylation genes.
The core set of genes in GO and KEGG oxidative phosphorylation (OXPHOS) gene
sets included genes for subunits of cytochrome c oxidase (the nuclear-encoded COX4I1,
COX6B2, COX7B, and COX7C and the mitochondrially-encoded MT-CO1, MT-CO2, and MTCO3) as well as those that aid in cytochrome c oxidase assembly (COX10 and COX11) (Figure
10A, B; SI Table 3.6). Cytochrome C oxidase is the terminal complex in the electron transport
chain and is crucial to maintaining a proton gradient across the inner mitochondrial membrane
for ATPase to synthesize ATP. These genes are of particular interest, because within
anthropoids, genes encoding the subunits of cytochrome c oxidase show an accelerated rate of
evolution in their sequences compared with any other placental mammals [165]. Here, we see a
cell type by species divergence in cytochrome c oxidase gene expression, where most of these
genes exhibit higher expression in human neurons (Figure 10A). There is also a clear trend of
mitochondrially-encoded genes that function in OXPHOS having significantly higher
expression in human cells, including those for cytochrome c oxidase subunits (MT-CO1, MTCO2, MT-CO3), but also mitochondrially-encoded ATP synthase (MT-ATP6) and
mitochondrially-encoded subunits of the NADH:ubiquinone oxidoreductase core of electron
transport chain complex I (MT-ND2, MT-ND3, MT-ND5, and MT-ND6) (Figure 10A).
A major difference between the GO and KEGG OXPHOS gene sets is that the KEGG
OXPHOS includes vacuolar-ATPase (V-ATPase) genes, whose major role is in acidification of
intracellular organelles, and have an important function in synaptic vesicle proton gradient
formation and maintenance [197, 198]. There is an intriguing pattern of enrichment for higher
expression of subunits of V-ATPases in a cell type by species manner (Figure 10). Three genes
for subunits of vacuolar ATPases (ATP6V0C, ATP6V0D1, and ATP6V1C2) are core enriched
genes in the KEGG OXPHOS gene set and are significantly enriched in CT-DE with higher
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expression in chimpanzee NPCs and astrocytes, but not neurons (Figure 10B). Furthermore,
only one of these vacuolar-ATPase genes is DE in a SPxCT manner (ATP6V1C2) (Figure 10B).
However, several other V-ATPase subunit genes are core enriched only in human neurons
(Figure 10B), most notably ATPV1E2 and ATPV0E2, both of which are core enriched and
significantly differentially expressed in human neurons. This shows that V-ATPases exhibit
significant DE between humans and chimpanzees, and that human neurons are distinct in VATPase gene expression from chimpanzee NPCs and astrocytes. Given the important function
of V-ATPases in synaptic vesicle formation for neurotransmitter signaling, this may imply an
important functional change in humans specifically in neurons.
3.4.6 Interspecies differential expression of important metabolite transporter genes in
neurons and astrocytes
It is widely accepted that neurons exhibit limited glycolytic capacity and that astrocytes
respond to signals associated with increased synaptic signaling by increasing glucose uptake
and subsequent aerobic glycolysis of that glucose to lactate, to be used as energy source
necessary by neurons [reviewed in 72, 175]. For this reason, we were interested in investigating
if there were interspecies gene expression differences in lactate transport, particularly in
neurons and astrocytes. The GO gene set ‘lactate transmembrane transport’ was enriched in
chimpanzee neurons and astrocytes, showing that genes involved in lactate transport are more
highly expressed in these mature cell types than NPCs (Figure 11A). Several genes in this gene
set are for proton-linked monocarboxylate transporters that transport pyruvate and lactate
(SLC16A11, SLC16A12, SLC16A13, and SLC16A6) that are all core enriched in neurons and
astrocytes (Figure 11A). SLC6A11 and SLC16A13 are also differentially expressed in SPxCT
ANOVA-like DE as well as an CT-DE manner, though SLC16A13 is not in astrocytes (Figure
11A). The enrichment for the lactate transmembrane transport gene set in chimpanzee neurons
and astrocytes and the corresponding DE of specific pyruvate and transporter genes between
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species’ suggest that chimpanzee neurons and astrocytes have the capacity to shuttle pyruvate
and lactate at a higher rate than human neurons and astrocytes.
In addition to lactate transmembrane transport enrichments, the glucose transport gene
set was significantly enriched in human neurons and astrocytes (Figure 9). There were two
hexokinase genes (HK1 and HK2) core enriched in this gene set that demonstrate lower
expression in chimpanzee NPCs but higher expression in human astrocytes (Figure 11B),
though only HK2 is significantly upregulated in human astrocytes by CT-DE analysis (Figure
11B). G6PC3 may not be significantly differentially expressed in any particular cell type, but it
is in the SPxCT DE comparison and does show insignificant but consistently higher expression
in all chimpanzee cell types (Figure 11B). SLC2A3 is a facilitative glucose transporter across
the cell membrane, and here, it exhibits core enrichment in all three human cell types by the
GSEA leading edge analysis, as well as moderately (though non-significant) higher expression
in human (Figure 11B). The enrichments of glucose transport in human neurons and astrocytes
appears to be influences by increased expression of plasma membrane associated glucose
transporters (e.g. SLC2A3) and enzymes that function in the earlier steps of glycolysis (HK1,
HK2, G6PC3).
3.4.7 Few genes exhibiting interspecies DE in iPSC-derived neural cells have signs of
positive selection in their coding regions
In order to begin to probe whether expression differences between species are
influenced by selective pressures, we obtained synonymous (dS) and nonsynonymous (dN)
nucleotide mutation rates from Ensembl [53, 54] and compared the rate of change (dN/dS) for
different groups of iPSC-derived neural cell expressed genes. A dN/dS > 1 indicates putative
evidence of positive selection in coding regions [192]. As predicted, the vast majority of all the
genes identified as expressed in these cells did not exhibit a dN/dS > 1 (SI Figure 23). Only a
few genes DE between species in iPSC-derived astrocytes (n=6), neurons (n=6), and NPCs
(n=11) exhibit signs of coding selection (dN/dS > 1) (Table 5, SI Figure 23). The gene HRC
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(histidine rich calcium binding protein) exhibits positive selection and is significantly DE
between species in NPCs, but not astrocytes, and is not expressed at all in neurons (Table 5).
Three genes (DCTN6, HHLA3, DBNDD2) have a dN/dS > 1and showed significantly DE in all
three cell types (Table 5). However, there is no commonality in these genes to suggest any
meaningful impact on gene expression differences or in specific cell types. This is likely due, in
part, to the limitations of the methods used for probing coding sequences, rather than those in
non-coding, cis-regulatory changes, which previous studies have demonstrated are critical for
significant differences in expression in primate brains [40-42].
3.4.8 Significant interspecies differences in the expression of aerobic glycolysis enzymes
are primarily in NPCs and astrocytes but not neurons
In order to obtain a pathway-level understanding of altered expression of aerobic glycolysis
in iPSC-derived neural cells between humans and chimpanzees, we reconstructed a signaling
network diagram of enzymes involved in four sub-pathways involved in aerobic glycolysis
(glycolysis, pentose phosphate pathway, pyruvate conversion to lactate, and the citric acid
(TCA) cycle) from the HumanCyC database (Figure 12) [193]. We then mapped discrete
expression values (higher in human, higher in chimpanzee, not expressed) for each of these
enzymes in all three cell types onto the pathway diagram to illustrate which species the enzymes
were more highly expressed in and if they were significantly differentially expressed between
species in which cell types. From this, we see dynamic changes in expression across these
aerobic glycolysis sub-pathways, with no significant shift towards higher expression of enzymes
in one species or cell type at any of these sub-pathways (Figure 12). Aerobic glycolysis
enzymes exhibiting interspecies DE in NPCs were PGD, LDHA, LDHB, LDHC, and ME1,
enzymes demonstrating DE in astrocytes were PGD, HK2, PDHA1, FH, ACO2, and SDHD, and
only a single enzyme exhibited interspecies DE in neurons (LDHB) (Figure 12). This shows that
NPCs and astrocytes, but not neurons, exhibit the vast majority of significant differences in
expression of enzymes in these pathways (Figure 12). The vast majority of these genes were

90

expressed in all cell types, particularly those that exhibited significant DE in NPCs or
astrocytes, so this lack of DE in neurons is not simply due to cell-type specific expression
differences (SI Figure 24). Human and chimpanzee astrocytes appear to diverge at the stage of
pyruvate utilization, where human astrocytes exhibit significantly higher expression of PDHA1,
which converts pyruvate into acetyl-coA whereas chimpanzee astrocytes show significantly
higher expression of LDHB, which converts pyruvate into lactate rather than acetyl-coA (Figure
12). Interestingly, LDHB is also the only enzyme in these pathways exhibiting differential
expression between species in neurons. Other LDH isoforms (LDHC and LDHA) also exhibit
significant interspecies DE, with higher expression in chimpanzee NPCs. All chimpanzee neural
cell types differ from human chimpanzees for LDH expression, but NPCs differ from humans in
expression levels of multiple LDH isoforms. This pathway level consideration expression
differences between species suggests significant changes in aerobic glycolysis enzyme activity
primarily in NPCs and astrocytes and an interspecies divergence in pyruvate utilization.
3.5 Discussion
This study represents, to our knowledge, the only investigation of neuronal cell-type
specific differences in gene expression divergence across primate species. Our novel approach
using iPSCs work allowed us to investigate rare neural cell types from primates to determine
cell type specific metabolic changes necessary to support evolution of the human brain. Our
results demonstrate interspecies divergence in gene expression is more conserved in neurons
and significantly greater between species’ astrocytes. Differential expression between species’
cell types is enriched for metabolic processes – similarly to that of previous studies of
differential expression between human and chimpanzee whole brain tissue – and is driven
primarily by higher expression of metabolic genes in human cells [42, 161, 162]. We also
determined that human neurons and astrocytes are enriched for higher expression of glucose
transport proteins while chimpanzee neurons and astrocytes exhibit higher expression of lactate
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transmembrane transport genes and that there are dynamic interspecies changes in expression of
nuclear- and mitochondrially-encoded subunits of the protein complexes important for oxidative
phosphorylation. Our study demonstrates the utility of iPSC-derived cells for better
understanding evolution of gene expression in primates.
Though there were many important differences in metabolic expression between human
and chimpanzee brains, the heterogenous nature of brain tissue complicated drawing specific
conclusions about role of specific cell types on this trajectory of elevated metabolic expression
in human brains. There have been long-standing questions about sole influence of greater
neuron numbers in human brains [143] on the observed increase in glucose utilization [84, 85].
Our novel approach using iPSC-derived neural cell types and compairing gene expression
differences in a cell type by species manner allowed us to test interspecies differences in the
cell-type specific contribution of metabolism to long-understood differences in brain metabolic
capacity. Because our methods of detrmining signficant differences in gene expression do not
rely on number of cells or quantity of transcripts, we are able to conclude that there are cell-type
specific contributions to altered metabolic gene expression between species’ neural cell ttypes,
and that sheer number of cells alone likely does not fully explain metabolic differences between
human and chimpanzee brains.
Our results demonstrate that, in light of the relatively recent discovery of cell-type
specific metabolic differences between neurons and astrocytes, investigation of differences in
brain metabolism among primates and the evolutionary processes that shaped them would
indeed be incomplete without the consideration of all metabolically-relevant neural cell types,
not just neurons. We determined that astrocytes demonstrate the greatest proportion of
interspecies difference in metabolic gene expression, and that, in fact, neuronal gene expression
is more conserved across species. This suggests that astrocyte-mediated differences in metabolic
brain function may be an important mechanism by which the ultimate evolutionary trajectory of
human brain evolution has occurred.
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Human cells show increased capacity for glucose transport, via greater expression of
glucose transporters, into the mature neural cell types. This may suggest that the observed
differences in glucose utilization by the human brain extend beyond development and may play
an important role in more mature neurons and astrocytes for either energy or macromolecule
production. Furthermore, lactose dehydrogenase (LDH) isoforms favor differential affinities for
interconverting pyruvate and lactate. LDHB favors the production of lactate into pyruvate, and
is significantly differentially expressed with higher expression in chimpanzee for all cell types
[71, 199]. This, coupled with the increase in lactate transporters in chimpanzee astrocytes,
suggests that chimpanzee cells may be favoring production and transport of lactate at a higher
rate than human neural cell types. This opposing enrichment for elevated glucose transport in
mature human neural cell types in comparison to elevated lactate transport and conversion to
pyruvate raises some intriguing questions about metabolic trade-offs between human and
chimpanzee brains. If we presume that the direction of change in metabolic gene expression is
on the human lineage, and we do have some evidence from signs of positive selection on
glucose and energetic metabolism coding and non-coding genes within primates with proximity
to humans [162, 166-169], then has an increase in glucose uptake in human brains allowed for a
coinciding decrease in gene expression focusing on converting and shuttling lactate (LDH and
lactate transport) to produce pyruvate? Our current analysis of evidence of selection in genes
exhibiting DE between species CTs did not reveal much insight. However, expanding this
investigating into a more nuanced investigation of positive selection in non-coding regions of
known function in altering expression levels of these interspecies DE genes would provide a
more definitive assessment of the correlation between the functional changes we see here in
aerobic glycolytic expression and the selective pressures that shaped it. Similarly, previous
studies have found lineage-dependent differences in enrichments for metabolic pathways in
genes DE between primate brain regions, where glucose and carbohydrate metabolism in
elevated in humans and glycogen and acyl-CoA metabolism in chimpanzees [42, 161, 162]. The
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increase in LDH and lactate transport in chimpanzee neurons and astrocytes may be a
mechanism by which these previous findings of altered metabolic signaling at the whole tissue
level occurred.
Human neural cells were enriched at the pathway level for oxidative phosphorylation
genes, and within that pathway, there were some interesting examples of opposing enrichment
for subunits of oxidative phosphorylation protein complexes. We not only saw increased
expression and enrichment for components of cytochrome c oxidase, which previous studies
have already determined genes involved in this complex to be under positive selection [166].
However, we expand on the knowledge of interspecies differences in cellular respiration
complex expression by determining that these components are higher in human in all cell types
investigated though there is a more consistent enrichment for higher expression of all of these
genes in human neurons (Figure 10A). We also observed higher expression for subunits of other
electron transport chain complexes, including ATP-synthase and the NADH:ubiquinone
oxidoreductase components of complex I. This cell-type by species approach also allowed for
us to determine that there are oxidative phosphorylation genes where human neurons and
chimpanzee NPCs and astrocytes have higher expression for genes involved in vacuolarATPase function. Astrocytes respond to signals associated with increased synaptic signaling
[reviewed in 72, 175] by increasing glucose uptake and subsequent aerobic glycolysis of that
glucose to lactate, which is the energy source necessary for neurons. This suggests that VATPases are significantly differentially expressed between humans and chimpanzees, and that
human neurons are distinct in V-ATPase gene expression from chimpanzee NPCs and
astrocytes. Given the important function of V-ATPases in synaptic vesicle formation for
neurotransmitter signaling, this may imply an important functional change in humans
specifically in neurons.
Our investigation into the overlap of signatures of positive selection with genes
exhibiting interspecies DE revealed very little new or intriguing information. This is likely due
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at least in part to the limited scope of the current methods for searching for positive selection.
The dN and dS scores obtained from Ensembl for use in this analysis were averages across all
sites in a given gene, thus minimizing significant changes at specific sites [200]. More
importantly, it is necessary to investigate positive selection in both coding and non-coding
regulatory regions (i.e. promoters, cis-regulatory regions) associated with metabolic genes, as
changes in both gene sequence and gene expression can confer adaptive phenotypic differences
[39, 41, 42, 161, 162]. Non-coding regulatory regions of genes in oxidative phosphorylation and
glycolysis pathways are found to be under positive selection to varying degrees in humans [39].
A specific example is glucose-6-phosphate isomerase (GPI), which has been determined to be
under positive selection in its non-coding promoter region in previous studies [42], however, it
does not exhibit interspecies DE in any of these cell types. Future investigations of the overlap
between genes exhibiting DE in a cell-type specific manner and signatures of positive selection
should utilize methods that allow for branch and site models that are more effective at
determining positive selection in a lineage-specific manner (e.g. HyPhy for non-coding and
coding regions) [42, 201-203].
Our focal analysis of aerobic glycolysis enzyme expression had a few important findings.
First, we show that there is consistent a single species-skew in expression levels for any of the
four sub-pathways in aerobic glycolysis. The lack of significant DE between species in neurons
for aerobic glycolysis enzymes demonstrates the importance of studying cell types other than
neurons for better understanding human brain evolution and suggests that astrocytes may
indeed be critical for the evolution of human-specific brain gene expression. Secondly, we
found that it is not simply the lack of glycolytic capacity of neurons [171-173] that contribute to
cell-type specific signaling disparities, at least in a comparative manner. Lastly, perhaps the
most intriguing finding is the interspecies divergence in processing pyruvate – humans exhibit
significantly higher expression of PDHA1 than chimpanzees do, indicative of a functionally
relevant increase in conversion of pyruvate into acetyl-CoA and further utilization of the
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products of glycolysis for energy production, while chimpanzee astrocytes exhibit expression
phenotypes suggestive of greater lactate production (higher expression of LDH, which converts
pyruvate to lactate) as well as enrichment for greater lactate transmembrane transport in
chimpanzee neural cell types (higher expression of lactate transmembrane transporters). This
suggests that chimpanzee neural cells, and most prominently astrocytes, have a significantly
greater capacity to convert pyruvate into lactate and then shuttle it across membranes than
human astrocytes do. These analyses suggest significant interspecies changes in aerobic
glycolysis enzyme activity primarily in NPCs and astrocytes and an interspecies divergence in
pyruvate utilization.
A potential drawback to a cell-type specific study of interspecies differences in
neuronal gene expression is the loss of intercellular signaling between different cell types, a
hallmark of synaptic signaling in whole tissue. Furthermore, the astrocyte-neuron lactate shuttle
links the complementary metabolic needs of astrocytes and neurons [reviewed in 72, 175].
Neurons are considered largely to lack the ability to increase glycolytic activity. Future studies
of gene expression differences with controlled levels of intercellular signaling by building in
complexity (e.g. interspecies differences in expression of single cell types compared to that of
co-cultured iPSC-derived neurons and astrocytes) could further inform interspecies differences
in neuronal gene expression. We also determined cell-type by species differences in gene
expression for nuclear- and mitochondrially-encoded subunits of the protein complexes
important for oxidative phosphorylation. Finally, we show a significant interspecies divergence
in aerobic glycolytic gene expression in astrocytes, suggesting that this traditionally
understudied glial cell type likely contributes to the tissue-level shifts in gene expression and
suggests that astrocytes play an important role in the evolution of the metabolically expensive
human brain.
3.6 Conclusion
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Evolved differences in metabolic investment may be the basis for a number of primatespecific phenotypes, including those that are uniquely-human, such as slow reproduction and
growth and correspondingly longer lifespan than other placental mammals [151, 204, 205].
Adaptation can act on metabolic phenotypes through alterations to energy budget including
reductions of or increases in total energy budget or differential allocation of energy within
energy budget [151, 206, 207]. Our results demonstrate that altered gene expression between
species’ astrocytes - an under-studied, but critical brain cell type with known metabolic
relevance, providing insight into the metabolic changes that were necessary to support evolution
of the human brain.
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3.7 Supplemental Information Table List
SI Table 3.1 | Sample, cell line, and sequencing information.
SI Table 3.2 | External RNA-Seq Metadata from Gene Expression Omnibus.
SI Table 3.3 | Lists of DE genes from edgeR.
SI Table 3.4 | Categorical enrichment analyses results from gProfiler.
SI Table 3.5 | GSEA Pathway enrichment table.
SI Table 3.6 | Table of leading edge analyses of genes in three significant GSEA pathways.
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3.8 Main Figures and Tables
Figure 7
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Figure 7 | Patterns of gene expression variation of iPSC-derived neural cells from humans and
chimpanzees. A) The differentiation schematic and representative immunofluorescent photos of
iPSC-derived neural progenitor cells (NPCs; line H28815) stained with PAX6, astrocytes (line
C3649K) stained with GFAP, and neurons (line C4955) stained with TUJ1. B) A PCoA of the
iPSC-derived NPCs, neurons, and astrocytes transcriptomes. C) A Venn diagram of the overlap
in expression across cell types. Further details for samples are included in SI Table 1.
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Figure 8
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Figure 8 | Astrocytes demonstrate the most significant differences in gene expression between
human and chimpanzee neural cell types for metabolic but not neuron-specific pathways. A)
Counts of genes exhibiting differential expression at an FDR < 5% between species for each
cell type and the direction of higher expression for each CT-DE comparison (red/positive –
higher expression in human; blue/negative – higher expression in chimpanzee). B) A Venn
diagram of overlap in genes per cell type exhibiting differential expression between species. C)
Plot of significantly (EASE < .05) over-represented (top panel) and under-represented (bottom
panel) KEGG pathways determined by categorical enrichment analyses (full results in SI Table
4). Size indicates the count of genes per pathway while color indicates the adjusted p-value
(pink – lower/significant, brown – higher/non-significant). D) Plot of significantly overrepresented categories of GO BP terms determined by categorical enrichment analyses. (full
results in SI Table 4). The categories (y-axis) represent groupings of multiple GO BP terms
related to the metabolism of the indicated substrates/macromolecules. Size indicates the mean
count and color indicates the mean adjusted enrichment p-value for all terms in that category.
Refer to SI Table 4 and Methods for individual GO BP terms included in each category.
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Figure 9
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*
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Figure 9 | Humans and chimpanzees differ in metabolite transport and oxidative
phosphorylation in a neural cell-type manner. A) Plot of all tested gene sets in the Gene Set
Enrichment Analysis (GSEA) (full results in SI Table 5). Separate panels indicate which
species ‘phenotype’ the gene set was enriched in. Color indicates the FDR Q-value (FDR < 25%
indicates significance in this analysis). Size indicates the log(count) of genes included in the
enriched gene set. B) Enrichment plots of significant pathways from GSEA for a subset of
panel A. The green line indicates the running enrichment score for each gene in the gene set as
the analysis moves down the ranked list of genes. The enrichment score for the gene set is the
peak of this curve and an (*) indicates significantly enriched. The bottom panel is the ranked
order of the genes and shows their location within that ranked set of genes. Left side of plot
(and red/left portion of ranked order plot below) indicates human enrichment, while the
opposite (right/blue) indicates chimpanzee enrichment. Full results in SI Table 5.
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Figure 10
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Figure 10 | Interspecies expression differences of oxidative phosphorylation genes is influenced
by higher expression of mitochondrial genes in all neural human cell types. CT-DE results of
genes per A) GO or B) KEGG oxidative phosphorylation gene sets determined as members of
the core set genes influencing significant enrichment of these gene sets in the GSEA analysis.
CT-DE rank per each gene (x-axis) - values greater than zero indicate higher expression in
human and values less than zero indicate higher expression in chimpanzee. Color spectrum and
size also indicate rank (red – higher in human, blue – higher in chimpanzee, larger = higher
rank). See SI Table 3 for DE results per gene and SI Table 6 for GSEA results per gene.
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Figure 11 | Neurons and astrocytes exhibit contrasting interspecies differences in lactate and
glucose transport. Comparison of genes involved in the A) GO lactate transmembrane transport
and B) REACTOME glucose transport gene sets determined as significantly enriched in one
species by GSEA analyses. Each panel (white, grey, and black) indicates significance per gene
for one of the functional enrichment analyses used (top/white - interspecies DE by cell type
(CT-DE); middle/grey – SPxCT ANOVA-like DE, bottom/black – membership in core
enrichment genes of leading edge GSEA analysis). (Top panel) Plot of CT-DE rank per each
gene (x-axis), where values greater than zero indicate higher expression in human and values
less than zero indicate higher expression in chimpanzee. Color spectrum and size also indicate
rank (red – higher in human, blue – higher in chimpanzee, larger = higher rank). (Dark grey
panel) Plot of FDR for each gene in the ANOVA-like SPxCT DE comparison, where color
indicates significance (pink – lower/significant, brown – higher/non-significant) and size also
indicates significance (1-FDR, larger = more significant). (Black panel) Plot of whether each
gene was part of the core set of genes in GSEA leading edge analysis (black – yes, white – no).
See SI Table 3 for DE results per gene and SI Table 6 for GSEA results per gene.
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Table 5

Gene ID

Gene Name

dN/dS

DCTN6
NBPF3
CA2
CDCA5
HHLA3
DBNDD2
PCYT1A
HRC
LIN9
IMPG1
EME1
TMEM140
CD24

dynactin subunit 6
NBPF member 3
carbonic anhydrase 2
cell division cycle associated 5
HERV-H LTR-associating 3
dysbindin domain containing 2
phosphate cytidylyltransferase 1, choline, alpha
histidine rich calcium binding protein
lin-9 DREAM MuvB core complex component
interphotoreceptor matrix proteoglycan 1
essential meiotic structure-specific endonuclease 1
transmembrane protein 140
CD24 molecule

1.59
1.54
1.53
1.52
1.45
1.16
1.14
1.13
1.11
1.08
1.06
1.03
1.01
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logFC
NPC NEU AST
-1.33 -1.43 -1.64
-1.48
3.81
-0.08
5.35
-4.15
1.29
2.12
1.32
-4.39
-0.75
1.88
2.66

-1.09
4.18
-0.34
4.93
-4.54
2.16
NA
1.04
-2.07
-1.47
1.76
3.15

-0.80
0.47
1.51
3.97
-3.40
1.56
2.23
1.81
-2.32
0.30
1.48
2.64

Table 5 | Interspecies differentially expressed genes with evidence of coding selection. In order
to determine if genes exhibiting significant interspecies differential expression also had
evidence of positive selection in their coding sequences, we used nonsynonymous (dN) and
synonymous (dS) nucleotide changes per gene for all genes expressed in iPSC-derived neural
cells. A rate of change was calculated for each gene (dN/dS), where a dN/dS > 1 is indicative of
positive selection. logFC from CT-DE comparisons are listed for each gene; color indicates
degree of logFC and species with higher expression (red, human; blue, chimpanzee). Bolded
logFC values indicate they are significantly DE between species in that cell type.
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Figure 12

111

Figure 12 | Divergence in pyruvate utilization between species’ astrocytes. We constructed a
focal set of aerobic glycolysis signaling pathways in order to contextualize our DE results in the
framework of a network signaling. A diagram of the major pathways involved in aerobic
glycolysis (glycolysis, pentose phosphate pathway (PPP), lactate conversion from pyruvate, and
TCA cycle). For each enzyme in the pathway, three blocks indicate expression of this enzyme
in each cell type – left to right: NPCs, neurons, astrocytes. Color indicates level of expression
(higher in human (red), higher in chimpanzee (blue), not expressed in this cell type (grey)).
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SI Figure 13 | Differentiation and maturation of a human and chimpanzee iPSC lines into
neural cell types. Immunofluorescent validation of matched-by-cell-line iPSC-derived neurons
and astrocytes. Left column is images of cells immunofluorescently labeled for neuron-specific
class III b-tubulin (TUJ1; Neuromics), and the right column is images of iPSC-derived
astrocytes immunofluorescently labeled for GFAP (Sigma Aldrich), according to
manufacturer’s suggestions. All cells for each cell type were harvested at similar timepoints:
neurons at passage 3-4 and mature astrocytes at passage 5-6 post-differentiation from NPCs (SI
Table 1).
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SI Figure 14
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0.5

SI Figure 14 | MDS plots of all iPSC-derived samples with shape indicating cell line. The same
MDS plots for A) all genes expressed and B) the top 500 more differentially expressed genes as
in main Figure 1C where shape indicates individual cell lines.
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SI Figure 15
SI Fig. 3
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SI Figure 15 | MDS plots of individual cell types ( A & D – NPCs, B & E – neurons, C & F –
astrocytes). Plots A-C are for the top 500 most differentially expressed genes while plots D-F
are for all genes expressed.
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SI Figure 16
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SI Figure 16 | MDS plots of all A & C) human and B & D) chimpanzee samples by cell type.
Plots A & B are for the top 500 most differentially expressed genes while plots C & D are for
all genes expressed.
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SI Figure 17
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SI Figure 17 | Human and chimpanzee iPSC-derived neural cells resemble primary neural cell
types and tissue regions more than non-neuronal tissues. A PCoA of the iPSC-derived neural
cells in comparison to whole-tissue RNA-Seq from four brain regions (cerebellum,
hippocampus, prefrontal cortex, and visual cortex) from human and chimpanzee (3 individuals
per species) (Babbitt et al , in prep.), brain and non-neuronal tissue from human and
chimpanzee from [45], as well as that from primary neurons and astrocytes [186-188] obtained
from the Gene Expression Omnibus (GEO) [185] Short Read Archive (SRA) (GEO accession
numbers GSE30352, GSE73721, GSM2071331, GSM2071332, and GSM2071418). Label
shape indicates the sample source tissue or cell type. Color refers to cell type or brain region.
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SI Figure 18 | Distribution of differentially expressed genes between species for each cell type.
MA plots of expression of all genes (average log CPM, x-axis) by their relative log fold-change
(y-axis) from TopTags tables of pairwise, interspecies CT-DE comparisons made in edgeR for
A) NPCs, B) neurons, and C) astrocytes. Color indicates differential expression status: black –
non-DE, red – DE with higher expression in human, blue – DE with higher expression in
chimpanzee). Number of genes identified as differentially expressed with higher expression in
human and indicated in red text; for chimpanzee, in blue text.
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SI Figure 19
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SI Figure 19 | Overlap in interspecies CT-DE genes. Weighted (left column) and unweighted
(right column) Venn diagrams made using R package Vennerable of overlap in genes per cell
type exhibiting differential expression between species. Venn diagrams are for all CT-DE genes
across all CT’s (A) and DE genes across all CT-DE comparisons with higher expression in
human (B) or chimpanzee (C).
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SI Figure 20 | GO Biological Process (BP) enrichments. Plots of significantly over-represented
(top panels) and under-represented (bottom panels) categories of GO BP terms determined by
categorical enrichment analyses in genes with higher expression in chimpanzee (left panel) and
human (right panel) for each cell type (x-axis). The categories (y-axis) represent groupings of
multiple GO BP terms grouped by their general function. Size indicates the mean count and
color indicates the mean adjusted enrichment p-value for all terms in that category.
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SI Figure 21 | GO Cellular Component (CC) enrichments. Plots of significantly overrepresented (top panels) and under-represented (bottom panels) categories of GO CC terms
determined by categorical enrichment analyses in genes with higher expression in chimpanzee
(left panel) and human (right panel) for each cell type (x-axis). The categories (y-axis) represent
groupings of multiple GO CC terms grouped by their A) by their broad cell region and B)
functions related to the cellular components enriched. Size indicates the mean count and color
indicates the mean adjusted enrichment p-value for all terms in that category.
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SI Figure 22 | GO Molecular Function (MF) enrichments. Plots of significantly overrepresented (top panels) and under-represented (bottom panels) categories of GO MF terms
determined by categorical enrichment analyses in genes with higher expression in chimpanzee
(left panel) and human (right panel) for each cell type (x-axis). The categories (y-axis) represent
groupings of multiple GO MF terms grouped by their A) binding activity for particular
substrates and B) specificity types of molecular activity. Size indicates the mean count and
color indicates the mean adjusted enrichment p-value for all terms in that category.
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SI Figure 23

dN/dS

(Expressed)

(DE)

(DE)

Groups of Genes

133

(DE)

SI Figure 23 | Positive selection in genes expressed in iPSC-derived neural cells. In order to
determine if genes exhibiting significant interspecies differential expression also had evidence
of positive selection in their coding sequences, we used nonsynonymous (dN) and synonymous
(dS) nucleotide changes per gene for all genes expressed in iPSC-derived neural cells. A rate of
change was calculated for each gene (dN/dS), where a dN/dS > 1 is indicative of positive
selection.
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SI Figure 24
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SI Figure 24 | Full expression network of sub-pathways in aerobic glycolysis. We constructed a
focal set of aerobic glycolysis signaling pathways in order to contextualize our DE results in the
framework of a network signaling. A diagram of the major pathways involved in aerobic
glycolysis (glycolysis, pentose phosphate pathway (PPP), lactate conversion from pyruvate, and
TCA cycle). For each enzyme in the pathway, three blocks indicate expression of this enzyme
in each cell type – left to right: NPCs, neurons, astrocytes. Color indicates level of expression
(DE and higher in human (red), DE and higher in chimpanzee (blue), not expressed in this cell
type (grey), expressed but not DE (black)).
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CONCLUSIONS

My dissertation work has significantly increased the taxonomic, tissue, and cell type
breadth of primate transcriptome data. It includes the first in-depth investigation into V1
expression changes across such a phenotypically and phylogenetically distinct set of primates
and demonstrates that alterations in metabolic signaling play an important role in evolved
differences in V1 gene expression. These differences in V1 expression likely overlap with that
of other brain regions, given that it is a cortical region that as a whole has experienced
significant evolutionary change over primate evolution, particularly in the human lineage.
However, given the significant differences observed even between the relatively recently
diverged human and chimpanzee, some of these metabolic and neuron-specific signaling
changes may be uniquely important to V1. Future studies with more sophisticated analytical
approaches may be able to determine this.
Despite the known importance of vision in primate evolution, my first chapter
represents one of very few investigations of the V1 region at the level of gene expression. V1
has historically been well-studied at the tissue level, particularly in rhesus macaques (Macaca
mulatta), but any previous investigations of V1 at the expression level have been limited in
species number and variability (to human, chimpanzee, and macaque) and have largely been
more focused on other brain regions. These analyses, though nuanced and not without important
caveats, also represent one of few studies attempting to link gene expression changes in a
visual-stimuli sensing brain region with that of visually-relevant, putatively adaptive primate
phenotypes. Our finding of significant expression differences in V1 associated with differences
in a proxy for sociality and the inclusion of genes of known function in sociality (OXTR and
DRD4) are particularly intriguing. This work also demonstrates that despite significant
conservation in both DNA nucleotide sequence and visual processing systems between humans
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and chimpanzees, gene expression in V1 is substantially more different between these species
than other species.
There are a number of ethical and practical hurdles to investigating primate tissue and
cell samples. Additional novelty of my dissertation research has been taking an interdisciplinary
approach to investigating classic questions in biological anthropology – such as interspecies
differences in organism-level traits such as disease and brain metabolic demands – using
contemporary molecular and cellular in vitro techniques. The utility of relatively non-invasive
skin biopsies to obtain fibroblasts from humans and chimpanzees has been key to my
investigation of cell adhesion and migration in fibroblasts as well as neural-cell type specific
expression changes, given that the iPSCs were generated from fibroblast lines. Cellular level
and cell-type specific studies of evolved changes between species are fairly rare, and the
contributions of my dissertation to this niche field are significant. They serve to further
elucidate the proximate molecular mechanisms putatively influencing ultimate evolutionary
trajectories of human-specific evolution.
The fairly new field of evolutionary medicine aims to better understand human disease
by taking a comparative biology approach using the “natural experiment” of primate evolution.
However, studying species-level differences in complex disease phenotypes is inherently
difficult, for a number of practical (e.g. rarity of disease samples or individuals) or ethical (e.g.
laboratory experiments on human and non-human primates) reasons. My investigation of basic
biological differences in cell adhesion and migration represent a way to test hypotheses
regarding the molecular and cellular mechanisms that contribute to these species-level
differences. I determined that previously determined significant interspecies differences in focal
adhesion complexes in fibroblasts correlate with significant changes in in cell adhesion and
migration. In conjunction with Jason Pizzollo and colleagues, I also determined that these
changes correlate not only with altered focal adhesion gene expression during a wound healing
response, but by consistent increased expression of focal adhesion and cellular adhesion
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molecule genes by chimpanzee fibroblasts. Not only do these results inform the field of
evolutionary biology, but also provide putative pathway and gene level targets of humanspecific altered expression that may play important roles in the development of human epithelial
neoplasms.
Finally, our use of modern iPSC and cell differentiation technology has allowed us to
study specific neural cell types from both humans and chimpanzees. Importantly, we are the
only lab known to date to investigate astrocytes from chimpanzees. Astrocytes are a historically
understudied cell type in the brain, and recently, have been determined to have important
functions in synapse development and neural signaling, in addition to critical metabolic support,
and aberrations of these cell-type specific functions have been implicated in human neurological
disease. Human-specific differences in astrocyte function could further elucidate mechanisms of
human-specific disease. My results provide valuable insights into astrocyte-mediated
differences in metabolic brain function as a proximate mechanism by which the ultimate
evolutionary trajectory of human brain evolution may have occurred. Future studies
investigating the overlap in interspecies DE genes of astrocytes with signatures of molecular
selection in cis-regulatory regions can better determine the adaptive significance of this altered
expression. This could include investigations of epigenetic changes in chromatin accessibility
(e.g. ATAC-Seq).
The finding of species differences in pyruvate utilization across all neural cell types,
with humans exhibiting a greater capacity to produce acetyl-CoA while chimpanzees exhibit
higher expression of enzymes conferring conversion of pyruvate into lactate, could be further
investigated in a number of ways. RNA-Seq of co-cultured neurons and astrocytes would be an
important additional dataset for better understanding interspecies differences in the astrocyteneuron lactate shuttle. Metabolic profiling of each cell type using high-throughput cellular
assays (e.g. Agilent’s Seahorse glycolytic rate) could provide cellular-level evidence for
interspecies differences in cellular respiration. Finally, increasing the number of species
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considered - particularly of iPSC-derived astrocytes – to include rhesus macaque, common
marmoset, mice, and rats would allow us to better understand not only the evolutionary pattern
of altered aerobic glycolysis gene expression but also could elucidate how appropriate each of
these biomedical model organisms are for studying human-specific neural function.
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